Background	Background	NNP	B-NP
Fibronectin	Fibronectin	NNP	I-NP
can	can	MD	0
control	control	VB	0
many	many	JJ	0
aspects	aspects	NNS	0
of	of	IN	0
cell	cell	NN	0
behavior	behavior	NN	0
,	,	,	0
including	including	VBG	B-NP
cell	cell	NN	I-NP
growth	growth	NN	I-NP
,	,	,	0
migration	migration	NN	0
and	and	CC	0
differentiation	differentiation	NN	B-NP
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
.	.	.	0
Fibronectin	Fibronectin	NNP	B-NP
exists	exists	VBZ	0
in	in	IN	0
the	the	DT	0
blood	blood	NN	0
as	as	IN	0
a	a	DT	0
dimer	dimer	NN	B-NP
,	,	,	0
but	but	CC	0
in	in	IN	0
tissues	tissues	NNS	0
it	it	PRP	0
is	is	VBZ	0
in	in	IN	0
the	the	DT	0
form	form	NN	0
of	of	IN	0
an	an	DT	0
insoluble	insoluble	JJ	0
fibrillar	fibrillar	JJ	B-NP
matrix	matrix	NN	I-NP
.	.	.	0
The	The	DT	0
fibronectin	fibronectin	NN	B-NP
fibrillar	fibrillar	JJ	I-NP
form	form	NN	I-NP
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
the	the	DT	0
most	most	RBS	0
relevant	relevant	JJ	0
form	form	NN	0
in	in	IN	0
vivo	vivo	NN	B-NP
because	because	IN	0
this	this	DT	0
is	is	VBZ	0
the	the	DT	0
form	form	NN	0
with	with	IN	0
which	which	WDT	0
most	most	JJS	0
cells	cells	NNS	0
interact	interact	VBP	0
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
.	.	.	0
various	various	JJ	B-NP
line	line	NN	I-NP
of	of	IN	0
evidence	evidence	NN	0
suggest	suggest	VBP	0
that	that	IN	0
the	the	DT	0
fibrillar	fibrillar	JJ	B-NP
matrix	matrix	JJ	I-NP
form	form	NN	I-NP
of	of	IN	0
fibronectin	fibronectin	JJ	0
exerts	exerts	JJ	0
effects	effects	NNS	0
on	on	IN	0
cells	cells	NNS	0
that	that	WDT	0
are	are	VBP	0
not	not	RB	0
duplicated	duplicated	VBN	0
by	by	IN	0
the	the	DT	0
fibronectin	fibronectin	NN	B-NP
dimeric	dimeric	JJ	I-NP
form	form	NN	I-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
high	high	JJ	0
dimeric	dimeric	NN	B-NP
fibronectin	fibronectin	NN	I-NP
concentration	concentration	NN	I-NP
enhance	enhance	FW	0
cell	cell	FW	0
migration	migration	FW	0
whereas	whereas	FW	0
high	high	JJ	0
fibrillar	fibrillar	NN	B-NP
fibronectin	fibronectin	NN	I-NP
concentration	concentration	NN	I-NP
reduce	reduce	FW	0
cell	cell	FW	0
migration	migration	FW	0
[	[	-LRB-	0
2	2	LS	0
]	]	-RRB-	0
.	.	.	0
Also	Also	RB	0
,	,	,	0
inhibition	inhibition	VBG	0
of	of	IN	0
fibronectin	fibronectin	JJ	B-NP
matrix	matrix	JJ	I-NP
assembly	assembly	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
inhibit	inhibit	VB	0
cell	cell	NN	B-NP
growth	growth	NN	I-NP
in	in	IN	0
various	various	JJ	0
systems	systems	NNS	0
[	[	-LRB-	0
3	3	CD	0
4	4	CD	0
5	5	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
findings	findings	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
fibrillar	fibrillar	JJ	B-NP
fibronectin	fibronectin	NN	I-NP
may	may	MD	0
stimulate	stimulate	VB	0
signal	signal	VB	0
transduction	transduction	JJ	B-NP
pathway	pathway	NN	I-NP
in	in	IN	0
cells	cells	NNS	0
that	that	WDT	0
are	are	VBP	0
either	either	RB	0
not	not	RB	0
stimulated	stimulated	VBN	0
,	,	,	0
or	or	CC	0
only	only	RB	0
marginally	marginally	RB	0
stimulated	stimulated	VBN	0
,	,	,	0
by	by	IN	0
dimeric	dimeric	JJ	B-NP
fibronectin	fibronectin	NN	I-NP
.	.	.	0
Fibronectin	Fibronectin	JJ	B-NP
matrix	matrix	JJ	I-NP
assembly	assembly	NN	I-NP
is	is	VBZ	0
a	a	DT	0
cell-mediated	cell-mediated	JJ	0
process	process	NN	0
that	that	WDT	0
requires	requires	VBZ	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
integrin	integrin	NN	B-NP
[	[	-LRB-	0
1	1	CD	0
6	6	CD	0
7	7	CD	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
integrin	integrin	NN	B-NP
that	that	WDT	0
is	is	VBZ	0
primarily	primarily	RB	0
responsible	responsible	JJ	0
for	for	IN	0
assembling	assembling	VBG	B-NP
fibronectin	fibronectin	NN	I-NP
into	into	IN	0
the	the	DT	0
matrix	matrix	NN	B-NP
is	is	VBZ	0
α5β1	α5β1	NNP	0
,	,	,	0
although	although	IN	0
αvβ3	αvβ3	NNP	B-NP
,	,	,	0
αllbβ3	αllbβ3	NNP	B-NP
and	and	CC	0
α4β1	α4β1	NNP	0
can	can	MD	0
also	also	RB	0
function	function	VBP	0
in	in	IN	0
this	this	DT	0
capacity	capacity	NN	0
[	[	-LRB-	0
9	9	CD	0
10	10	CD	0
11	11	CD	0
12	12	CD	0
13	13	CD	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
integrins	integrins	VB	0
,	,	,	0
fibronectin	fibronectin	JJ	B-NP
matrix	matrix	JJ	I-NP
assembly	assembly	NN	I-NP
also	also	RB	0
depends	depends	VBZ	0
on	on	IN	0
self-association	self-association	JJ	B-NP
site	site	NN	I-NP
within	within	IN	0
fibronectin	fibronectin	NN	B-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
the	the	DT	0
N-terminal	N-terminal	JJ	B-NP
70	70	CD	0
kDa	kDa	JJ	B-NP
region	region	NN	I-NP
,	,	,	0
the	the	DT	0
1	1	CD	0
sttype	sttype	JJ	0
III	III	NNP	0
repeat	repeat	NN	0
and	and	CC	0
the	the	DT	0
10	10	CD	0
thtype	thtype	JJ	0
III	III	NNP	0
repeat	repeat	NNS	0
are	are	VBP	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
important	important	JJ	0
for	for	IN	0
the	the	DT	0
proper	proper	JJ	0
alignment	alignment	NN	0
of	of	IN	0
fibronectin	fibronectin	JJ	B-NP
molecule	molecule	NN	I-NP
during	during	IN	0
matrix	matrix	JJ	B-NP
assembly	assembly	NN	I-NP
[	[	-LRB-	0
15	15	CD	0
16	16	CD	0
17	17	CD	0
18	18	CD	0
19	19	CD	0
20	20	CD	0
21	21	CD	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
and	and	CC	0
others	others	NNS	0
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
a	a	DT	0
recombinant	recombinant	JJ	0
protein	protein	NN	B-NP
representing	representing	VBG	0
a	a	DT	0
portion	portion	NN	0
of	of	IN	0
the	the	DT	0
first	first	JJ	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
(	(	-LRB-	0
protein	protein	NN	B-NP
III1-C	III1-C	NN	I-NP
)	)	-RRB-	0
can	can	MD	0
affect	affect	VB	0
fibronectin	fibronectin	JJ	B-NP
matrix	matrix	JJ	I-NP
assembly	assembly	NN	I-NP
and	and	CC	0
cell	cell	NN	B-NP
growth	growth	NN	I-NP
[	[	-LRB-	0
2	2	CD	0
3	3	CD	0
4	4	CD	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
a	a	DT	0
mutant	mutant	JJ	B-NP
recombinant	recombinant	JJ	I-NP
fibronectin	fibronectin	JJ	I-NP
molecule	molecule	NN	I-NP
that	that	WDT	0
is	is	VBZ	0
lacking	lacking	VBG	0
the	the	DT	0
first	first	JJ	0
seven	seven	CD	0
type	type	NN	0
III	III	NNP	0
repeats	repeats	NN	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
lead	lead	VB	0
to	to	TO	0
defective	defective	JJ	B-NP
fibronectin	fibronectin	JJ	I-NP
matrix	matrix	JJ	I-NP
assembly	assembly	NN	I-NP
in	in	IN	0
cell	cell	NN	0
culture	culture	NN	0
and	and	CC	0
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
and	and	CC	0
to	to	TO	0
inhibition	inhibition	VB	0
of	of	IN	0
cell	cell	NN	0
proliferation	proliferation	NN	0
[	[	-LRB-	0
23	23	CD	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
Although	Although	IN	0
the	the	DT	0
matrix	matrix	NN	B-NP
produced	produced	VBN	0
with	with	IN	0
fibronectin	fibronectin	NN	B-NP
lacking	lacking	VBG	0
the	the	DT	0
first	first	JJ	0
seven	seven	CD	0
type	type	NN	0
III	III	NNP	0
repeats	repeats	NNS	0
was	was	VBD	0
somewhat	somewhat	RB	0
aberrant	aberrant	JJ	0
,	,	,	0
this	this	DT	0
study	study	NN	0
does	does	VBZ	0
show	show	NN	0
that	that	IN	0
some	some	DT	0
matrix	matrix	JJ	B-NP
assembly	assembly	NN	I-NP
can	can	MD	0
occur	occur	VB	0
without	without	IN	0
the	the	DT	0
first	first	JJ	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
several	several	JJ	0
approaches	approaches	NNS	0
reveal	reveal	VBP	0
that	that	IN	0
the	the	DT	0
fibronectin	fibronectin	JJ	B-NP
type	type	NN	I-NP
III	III	NNP	I-NP
repeats	repeats	NNS	0
,	,	,	0
and	and	CC	0
especially	especially	RB	0
the	the	DT	0
first	first	JJ	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
,	,	,	0
play	play	VB	0
important	important	JJ	0
roles	roles	NNS	0
in	in	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
fibronectin	fibronectin	JJ	B-NP
matrix	matrix	JJ	I-NP
assembly	assembly	NN	I-NP
and	and	CC	0
cell	cell	NN	B-NP
growth	growth	NN	I-NP
.	.	.	0
III1-C	III1-C	NNP	B-NP
is	is	VBZ	0
known	known	VBN	0
to	to	TO	0
inhibit	inhibit	VB	0
cell	cell	NN	0
proliferation	proliferation	NN	0
[	[	-LRB-	0
3	3	CD	0
4	4	CD	0
]	]	-RRB-	0
.	.	.	0
Recently	Recently	RB	0
,	,	,	0
III1-C	III1-C	NNP	B-NP
(	(	-LRB-	0
also	also	RB	0
known	known	VBN	0
as	as	IN	0
anastellin	anastellin	CD	B-NP
)	)	-RRB-	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
inhibit	inhibit	VB	0
angiogenesi	angiogenesi	NN	B-NP
,	,	,	0
and	and	CC	0
tumor	tumor	NN	B-NP
growth	growth	NN	I-NP
and	and	CC	0
metastasi	metastasi	NN	B-NP
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
present	present	JJ	0
study	study	NN	0
we	we	PRP	0
examine	examine	VBP	0
how	how	WRB	0
cells	cells	NNS	0
interact	interact	VBN	0
with	with	IN	0
and	and	CC	0
respond	respond	VB	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
,	,	,	0
with	with	IN	0
a	a	DT	0
particular	particular	JJ	0
focus	focus	NN	0
on	on	IN	0
signaling	signaling	VBG	0
through	through	IN	0
the	the	DT	0
Ras	Ras	NNP	B-NP
/	/	NNP	I-NP
ERK	ERK	NNP	I-NP
pathway	pathway	NN	I-NP
.	.	.	0
We	We	PRP	0
find	find	VBP	0
that	that	IN	0
cells	cells	NNS	0
can	can	MD	0
adhere	adhere	VB	0
and	and	CC	0
spread	spread	NN	0
on	on	IN	0
III1-C	III1-C	NNP	B-NP
and	and	CC	0
that	that	IN	0
two	two	CD	0
classes	classes	NNS	0
of	of	IN	0
receptors	receptors	JJ	B-NP
function	function	NN	I-NP
in	in	IN	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
;	;	:	0
integrin	integrin	NN	B-NP
and	and	CC	0
cell-surface	cell-surface	JJ	B-NP
proteoglycan	proteoglycan	NN	I-NP
.	.	.	0
Results	Results	NNS	0
Cell	Cell	JJ	0
attachment	attachment	NN	0
and	and	CC	0
spreading	spreading	VBG	0
on	on	IN	0
the	the	DT	0
first	first	JJ	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
of	of	IN	0
fibronectin	fibronectin	JJ	B-NP
III1-C	III1-C	NN	I-NP
is	is	VBZ	0
a	a	DT	0
recombinant	recombinant	JJ	0
fibronectin	fibronectin	JJ	B-NP
fragment	fragment	NN	I-NP
that	that	WDT	0
encompasses	encompasses	VBZ	0
most	most	RBS	0
of	of	IN	0
the	the	DT	0
first	first	JJ	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
,	,	,	0
but	but	CC	0
is	is	VBZ	0
missing	missing	VBG	0
the	the	DT	0
A	A	NNP	0
and	and	CC	0
b	b	NN	B-NP
β-strand	β-strand	NN	I-NP
of	of	IN	0
the	the	DT	0
repeat	repeat	NN	0
[	[	-LRB-	0
2	2	LS	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
had	had	VBD	0
previously	previously	RB	0
found	found	VBN	0
that	that	IN	0
III1-C	III1-C	NNP	B-NP
inhibited	inhibited	VBD	0
the	the	DT	0
normal	normal	JJ	B-NP
diploid	diploid	JJ	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
growth	growth	NN	I-NP
(	(	-LRB-	0
SMCs	SMCs	NNP	B-NP
)	)	-RRB-	0
in	in	IN	0
culture	culture	NN	0
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
.	.	.	0
During	During	IN	0
these	these	DT	0
experiments	experiments	NNS	0
we	we	PRP	0
noticed	noticed	VBD	0
that	that	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
III1-C	III1-C	CD	B-NP
in	in	IN	0
the	the	DT	0
culture	culture	NN	0
medium	medium	NN	0
affected	affected	VBD	0
the	the	DT	0
morphology	morphology	NN	0
of	of	IN	0
cells	cells	NNS	0
at	at	IN	0
early	early	JJ	0
times	times	NNS	0
after	after	IN	0
plating	plating	NN	0
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
1	1	CD	0
,	,	,	0
cells	cells	NNS	0
plated	plated	VBN	0
onto	onto	IN	0
fibronectin	fibronectin	JJ	B-NP
coated	coated	JJ	I-NP
dish	dish	NN	I-NP
attached	attached	VBN	0
and	and	CC	0
spread	spread	VBD	0
well	well	RB	0
,	,	,	0
typically	typically	RB	0
containing	containing	VBG	0
numerous	numerous	JJ	B-NP
lamellipodia	lamellipodia	NN	I-NP
per	per	IN	0
cell	cell	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
,	,	,	0
panel	panel	NN	B-NP
FN	FN	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
Cells	Cells	NNS	0
seeded	seeded	VBN	0
onto	onto	IN	0
fibronectin	fibronectin	JJ	B-NP
coated	coated	JJ	I-NP
dish	dish	NN	I-NP
with	with	IN	0
III1-C	III1-C	CD	B-NP
in	in	IN	0
the	the	DT	0
culture	culture	NN	0
medium	medium	NN	0
spread	spread	NN	0
more	more	RBR	0
extensively	extensively	JJ	0
and	and	CC	0
in	in	IN	0
a	a	DT	0
more	more	RBR	0
circular	circular	JJ	B-NP
pattern	pattern	NN	I-NP
at	at	IN	0
early	early	JJ	0
times	times	NNS	0
after	after	IN	0
plating	plating	NN	0
than	than	IN	0
cells	cells	NNS	0
plated	plated	VBN	0
on	on	IN	0
fibronectin	fibronectin	NN	B-NP
in	in	IN	0
the	the	DT	0
iii1-c	iii1-c	NN	B-NP
absence	absence	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
,	,	,	0
panels	panels	VBG	0
FN	FN	NNP	B-NP
and	and	CC	0
FN+C	FN+C	NNP	B-NP
,	,	,	0
and	and	CC	0
Fig.	Fig.	CD	0
1B	1B	CD	0
)	)	-RRB-	0
.	.	.	0
Cells	Cells	NNS	0
cultured	cultured	VBN	0
on	on	IN	0
fibronectin	fibronectin	NN	B-NP
for	for	IN	0
4	4	CD	0
hours	hours	NNS	0
show	show	VBP	0
approximately	approximately	RB	0
the	the	DT	0
same	same	JJ	0
extent	extent	NN	0
of	of	IN	0
spreading	spreading	VBG	0
as	as	IN	0
cells	cells	NNS	0
on	on	IN	0
fibronectin	fibronectin	NN	B-NP
plus	plus	CC	0
III1-C	III1-C	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1B	1B	NNP	0
)	)	-RRB-	0
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
III1-C	III1-C	NNP	B-NP
accelerated	accelerated	VBD	0
the	the	DT	0
rate	rate	NN	0
of	of	IN	0
spreading	spreading	VBG	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
but	but	CC	0
did	did	VBD	0
not	not	RB	0
affect	affect	VB	0
the	the	DT	0
eventual	eventual	JJ	B-NP
extent	extent	NN	I-NP
of	of	IN	0
spreading	spreading	VBG	0
.	.	.	0
The	The	DT	0
effect	effect	NN	0
on	on	IN	0
cell	cell	NN	0
morphology	morphology	NNS	0
was	was	VBD	0
specific	specific	JJ	0
for	for	IN	0
III1-C	III1-C	CD	B-NP
because	because	IN	0
the	the	DT	0
negative	negative	JJ	B-NP
control	control	NN	I-NP
protein	protein	NN	I-NP
III	III	NNP	I-NP
11-C	11-C	NNP	0
(	(	-LRB-	0
a	a	DT	0
recombinant	recombinant	JJ	0
protein	protein	NN	B-NP
derived	derived	VBN	0
from	from	IN	0
the	the	DT	0
11	11	CD	0
thtype	thtype	JJ	0
III	III	NNP	0
repeat	repeat	NN	0
in	in	IN	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
which	which	WDT	0
,	,	,	0
similar	similar	JJ	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
,	,	,	0
is	is	VBZ	0
missing	missing	VBG	0
the	the	DT	0
A	A	NNP	0
and	and	CC	0
b	b	NN	B-NP
β-strand	β-strand	NN	I-NP
of	of	IN	0
this	this	DT	0
repeat	repeat	NN	0
)	)	-RRB-	0
had	had	VBD	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
the	the	DT	0
morphology	morphology	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
,	,	,	0
panel	panel	NN	B-NP
FN+11C	FN+11C	NN	I-NP
,	,	,	0
and	and	CC	0
Fig.	Fig.	CD	0
1B	1B	CD	0
)	)	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
III1-C	III1-C	CD	B-NP
on	on	IN	0
cell	cell	NN	0
morphology	morphology	NNS	0
was	was	VBD	0
seen	seen	VBN	0
even	even	RB	0
when	when	WRB	0
the	the	DT	0
plates	plates	NN	0
had	had	VBD	0
not	not	RB	0
been	been	VBN	0
coated	coated	VBN	0
with	with	IN	0
fibronectin	fibronectin	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
,	,	,	0
panel	panel	NN	0
C	C	NNP	0
,	,	,	0
and	and	CC	0
Fig.	Fig.	CD	0
1B	1B	CD	0
)	)	-RRB-	0
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
intact	intact	JJ	0
fibronectin	fibronectin	NN	B-NP
was	was	VBD	0
not	not	RB	0
required	required	VBN	0
for	for	IN	0
cell	cell	NN	0
attachment	attachment	NN	0
and	and	CC	0
spreading	spreading	VBG	0
when	when	WRB	0
III1-C	III1-C	NNP	B-NP
was	was	VBD	0
in	in	IN	0
the	the	DT	0
culture	culture	NN	0
medium	medium	NN	0
.	.	.	0
Again	Again	RB	0
,	,	,	0
the	the	DT	0
negative	negative	JJ	B-NP
control	control	NN	I-NP
protein	protein	NN	I-NP
III	III	NNP	I-NP
11-C	11-C	NNP	0
had	had	VBD	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
cell	cell	NN	0
morphology	morphology	NNS	0
;	;	:	0
cells	cells	NNS	0
seeded	seeded	VBN	0
onto	onto	IN	0
uncoated	uncoated	JJ	B-NP
plate	plate	NN	I-NP
with	with	IN	0
III	III	NNP	0
11-C	11-C	NNP	0
in	in	IN	0
the	the	DT	0
culture	culture	NN	0
medium	medium	NN	0
remained	remained	VBD	0
rounded	rounded	VBN	0
and	and	CC	0
did	did	VBD	0
not	not	RB	0
appreciably	appreciably	RB	0
spread	spread	VBN	0
over	over	IN	0
several	several	JJ	0
hours	hours	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
,	,	,	0
panel	panel	NN	0
11C	11C	NN	0
,	,	,	0
and	and	CC	0
Fig.	Fig.	CD	0
1B	1B	CD	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
indicated	indicated	VBD	0
that	that	IN	0
III1-C	III1-C	NNP	B-NP
had	had	VBD	0
an	an	DT	0
effect	effect	NN	0
on	on	IN	0
the	the	DT	0
morphology	morphology	NN	0
of	of	IN	0
freshly	freshly	JJ	0
plated	plated	JJ	0
cells	cells	NNS	0
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
the	the	DT	0
plates	plates	NN	0
did	did	VBD	0
not	not	RB	0
need	need	VBP	0
to	to	TO	0
be	be	VB	0
coated	coated	VBN	0
with	with	IN	0
any	any	DT	0
adhesive	adhesive	JJ	B-NP
protein	protein	NN	I-NP
prior	prior	RB	I-NP
to	to	TO	0
seeding	seeding	VB	0
the	the	DT	0
cells	cells	NNS	0
with	with	IN	0
III1-C	III1-C	CD	B-NP
in	in	IN	0
the	the	DT	0
culture	culture	NN	0
medium	medium	NN	0
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
III1-C	III1-C	NNP	B-NP
may	may	MD	0
have	have	VB	0
adsorbed	adsorbed	VBN	0
onto	onto	IN	0
the	the	DT	0
tissue	tissue	NN	0
culture	culture	NN	0
plastic	plastic	NN	0
and	and	CC	0
that	that	IN	0
cells	cells	NNS	0
then	then	RB	0
attached	attached	VBN	0
and	and	CC	0
spread	spread	NN	0
on	on	IN	0
the	the	DT	0
adsorbed	adsorbed	JJ	B-NP
III1-C	III1-C	NN	I-NP
.	.	.	0
To	To	TO	0
directly	directly	RB	0
test	test	VB	0
whether	whether	IN	0
cells	cells	NNS	0
were	were	VBD	0
able	able	JJ	0
to	to	TO	0
bind	bind	VB	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
coated	coated	NN	I-NP
on	on	IN	0
a	a	DT	0
dish	dish	NN	0
,	,	,	0
various	various	JJ	0
concentration	concentration	NN	B-NP
of	of	IN	0
either	either	DT	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
III1-C	III1-C	NNP	B-NP
or	or	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
were	were	VBD	0
coated	coated	VBN	0
onto	onto	IN	0
dishes	dishes	NNS	0
and	and	CC	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
these	these	DT	0
substrates	substrates	NN	0
was	was	VBD	0
measured	measured	VBN	0
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
2	2	CD	0
,	,	,	0
cells	cells	NNS	0
attach	attach	VBP	0
well	well	RB	0
to	to	TO	0
fibronectin	fibronectin	VB	0
and	and	CC	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
to	to	TO	0
III	III	NNP	0
11-C	11-C	NNP	0
coated	coated	NN	0
on	on	IN	0
a	a	DT	0
dish	dish	NN	0
.	.	.	0
On	On	IN	0
a	a	DT	0
molar	molar	JJ	B-NP
basis	basis	NN	I-NP
,	,	,	0
III1-C	III1-C	NNP	B-NP
was	was	VBD	0
less	less	RBR	0
effective	effective	JJ	0
at	at	IN	0
supporting	supporting	VBG	0
cell	cell	NN	0
attachment	attachment	NN	0
than	than	IN	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
however	however	RB	0
,	,	,	0
it	it	PRP	0
was	was	VBD	0
clear	clear	JJ	0
that	that	IN	0
rat	rat	NN	B-NP
aortic	aortic	NN	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
do	do	VBP	0
attach	attach	VBN	0
and	and	CC	0
spread	spread	VBD	0
well	well	RB	0
on	on	IN	0
III1-C	III1-C	CD	B-NP
coated	coated	NN	I-NP
on	on	IN	0
a	a	DT	0
dish	dish	NN	0
.	.	.	0
The	The	DT	0
morphology	morphology	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
seeded	seeded	VBN	0
onto	onto	IN	0
the	the	DT	0
iii1-c-coated	iii1-c-coated	NN	B-NP
well	well	JJ	I-NP
was	was	VBD	0
indistinguishable	indistinguishable	VBN	0
from	from	IN	0
the	the	DT	0
morphology	morphology	NN	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
1A	1A	CD	0
,	,	,	0
panel	panel	NN	B-NP
C.	C.	NNP	I-NP
Role	Role	NNP	0
of	of	IN	0
integrin	integrin	NN	B-NP
in	in	IN	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
The	The	DT	0
attachment	attachment	NN	0
of	of	IN	0
RASMCs	RASMCs	JJ	0
to	to	TO	0
III1-C	III1-C	NNP	B-NP
was	was	VBD	0
analyzed	analyzed	VBN	0
further	further	JJ	0
to	to	TO	0
determine	determine	VB	0
the	the	DT	0
role	role	NN	0
played	played	VBD	0
by	by	IN	0
integrin	integrin	NN	B-NP
as	as	IN	0
iii1-c	iii1-c	NN	B-NP
potential	potential	JJ	I-NP
adhesive	adhesive	NN	I-NP
receptor	receptor	NN	I-NP
.	.	.	0
various	various	JJ	B-NP
integrin-blocking	integrin-blocking	JJ	I-NP
reagent	reagent	NN	I-NP
were	were	VBD	0
tested	tested	VBN	0
for	for	IN	0
their	their	PRP$	0
ability	ability	NN	B-NP
to	to	TO	0
block	block	VB	0
RASMC	RASMC	JJ	B-NP
attachment	attachment	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
and	and	CC	0
to	to	TO	0
fibronectin	fibronectin	VB	0
.	.	.	0
The	The	DT	0
adhesion	adhesion	NN	B-NP
of	of	IN	0
SMCs	SMCs	JJ	0
to	to	TO	0
fibronectin	fibronectin	NN	B-NP
is	is	VBZ	0
mediated	mediated	VBN	0
through	through	IN	0
β1	β1	CD	0
integrins	integrins	NNS	0
[	[	-LRB-	0
1	1	CD	0
26	26	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
confirmed	confirmed	VBD	0
these	these	DT	0
previous	previous	JJ	0
findings	findings	NNS	0
for	for	IN	0
our	our	PRP$	0
RASMCs	RASMCs	JJ	0
,	,	,	0
by	by	IN	0
showing	showing	VBG	0
a	a	DT	0
complete	complete	JJ	0
block	block	NN	0
of	of	IN	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
fibronectin	fibronectin	VB	0
by	by	IN	0
EDTA	EDTA	NNP	B-NP
(	(	-LRB-	0
an	an	DT	0
agent	agent	NN	B-NP
that	that	WDT	0
blocks	blocks	VBZ	0
all	all	DT	0
integrin	integrin	NN	B-NP
)	)	-RRB-	0
,	,	,	0
anti-β1	anti-β1	RB	B-NP
blocking	blocking	VBG	0
mAb	mAb	JJ	0
,	,	,	0
and	and	CC	0
RGD	RGD	NNP	B-NP
peptide	peptide	NN	I-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
by	by	IN	0
the	the	DT	0
negative	negative	JJ	B-NP
control	control	NN	I-NP
RAD	RAD	NNP	I-NP
peptide	peptide	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3A	3A	NNP	0
)	)	-RRB-	0
.	.	.	0
anti-fibronectin	anti-fibronectin	NN	B-NP
antibody	antibody	NN	I-NP
also	also	RB	0
effectively	effectively	RB	0
blocked	blocked	VBN	B-NP
RASMC	RASMC	NNP	I-NP
attachment	attachment	VBD	I-NP
to	to	TO	0
fibronectin	fibronectin	VB	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3A	3A	NNP	0
)	)	-RRB-	0
.	.	.	0
Heparin	Heparin	NNP	B-NP
did	did	VBD	0
not	not	RB	0
inhibit	inhibit	VB	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
fibronectin	fibronectin	VB	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3A	3A	NNP	0
)	)	-RRB-	0
,	,	,	0
however	however	RB	0
,	,	,	0
it	it	PRP	0
did	did	VBD	0
modestly	modestly	RB	0
reduce	reduce	VB	0
cell	cell	NN	0
spreading	spreading	VBG	0
on	on	IN	0
fibronectin	fibronectin	NN	B-NP
(	(	-LRB-	0
15	15	CD	0
%	%	NN	0
inhibition	inhibition	NN	0
of	of	IN	0
cell	cell	NN	0
spreading	spreading	NN	0
,	,	,	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
RASMC	RASMC	NNP	B-NP
adhesion	adhesion	VBD	I-NP
to	to	TO	0
fibronectin	fibronectin	NN	B-NP
is	is	VBZ	0
mediated	mediated	VBN	0
by	by	IN	0
β1	β1	CD	0
integrins	integrins	NNS	0
.	.	.	0
blocking	blocking	VBG	B-NP
study	study	NN	I-NP
indicated	indicated	VBD	0
that	that	DT	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
III1-C	III1-C	NNP	B-NP
was	was	VBD	0
partially	partially	RB	0
mediated	mediated	VBN	0
by	by	IN	0
β1	β1	CD	0
integrins	integrins	NNS	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
RASMC	RASMC	NNP	B-NP
attachment	attachment	NN	I-NP
was	was	VBD	0
partially	partially	RB	0
blocked	blocked	VBN	0
by	by	IN	0
EDTA	EDTA	NNP	B-NP
,	,	,	0
anti-β1	anti-β1	NNP	B-NP
mAb	mAb	NNP	I-NP
,	,	,	0
and	and	CC	0
RGD	RGD	NNP	B-NP
peptida	peptida	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3B	3B	NNP	0
)	)	-RRB-	0
,	,	,	0
indicating	indicating	VBG	0
the	the	DT	0
involvement	involvement	NN	0
of	of	IN	0
integrin	integrin	NN	B-NP
.	.	.	0
However	However	RB	0
,	,	,	0
cell	cell	NN	0
attachment	attachment	NN	0
was	was	VBD	0
also	also	RB	0
partially	partially	RB	0
blocked	blocked	VBN	0
by	by	IN	0
heparin	heparin	NN	B-NP
,	,	,	0
which	which	WDT	0
did	did	VBD	0
not	not	RB	0
inhibit	inhibit	VB	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
fibronectin	fibronectin	VB	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3Aand	3Aand	NNP	0
3B	3B	NNP	0
,	,	,	0
Hep	Hep	NNP	0
samples	samples	NNS	0
)	)	-RRB-	0
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
a	a	DT	0
non-integrin	non-integrin	JJ	B-NP
receptor	receptor	NN	I-NP
also	also	RB	0
mediated	mediated	JJ	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
.	.	.	0
A	A	DT	0
complete	complete	JJ	0
block	block	NN	0
of	of	IN	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
III1-C	III1-C	NNP	B-NP
was	was	VBD	0
only	only	RB	0
observed	observed	VBD	0
when	when	WRB	0
heparin	heparin	NN	B-NP
was	was	VBD	0
combined	combined	VBN	0
with	with	IN	0
blocking	blocking	VBG	B-NP
agent	agent	NN	I-NP
integrin	integrin	NNS	I-NP
;	;	:	0
e.g.	e.g.	CD	0
,	,	,	0
heparin	heparin	NN	B-NP
+	+	FW	0
anti-β1	anti-β1	NN	B-NP
mAb	mAb	NN	I-NP
or	or	FW	0
heparin	heparin	NN	B-NP
+	+	FW	0
RGD	RGD	NN	B-NP
peptide	peptide	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3B	3B	NNP	0
)	)	-RRB-	0
.	.	.	0
anti-fibronectin	anti-fibronectin	NN	B-NP
antibody	antibody	NN	I-NP
modestly	modestly	RB	0
inhibited	inhibited	JJ	0
cell	cell	NN	0
attachment	attachment	NN	0
,	,	,	0
but	but	CC	0
anti-iii	anti-iii	NN	B-NP
1-c	1-c	NN	I-NP
antibody	antibody	NN	I-NP
effectively	effectively	RB	0
blocked	blocked	VBN	B-NP
cell	cell	NN	I-NP
attachment	attachment	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3B	3B	NNP	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
demonstrate	demonstrate	VBP	0
that	that	DT	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
III1-C	III1-C	NNP	B-NP
was	was	VBD	0
mediated	mediated	VBN	0
through	through	IN	0
both	both	DT	0
β1	β1	CD	0
integrins	integrins	NNS	0
and	and	CC	0
another	another	DT	0
class	class	NN	0
of	of	IN	0
receptor	receptor	NN	B-NP
on	on	IN	0
RASMCs	RASMCs	JJ	0
.	.	.	0
One	One	CD	0
way	way	NN	0
in	in	IN	0
which	which	WDT	0
integrin	integrin	NN	B-NP
were	were	VBD	0
originally	originally	RB	0
shown	shown	VBN	0
to	to	TO	0
be	be	VB	0
fibronectin	fibronectin	JJ	B-NP
receptor	receptor	NN	I-NP
was	was	VBD	0
by	by	IN	0
radioiodinated	radioiodinated	JJ	B-NP
cell	cell	NN	I-NP
surface	surface	NN	I-NP
protein	protein	NN	I-NP
affinity	affinity	JJ	I-NP
chromatography	chromatography	NN	I-NP
on	on	IN	0
a	a	DT	0
fibronectin	fibronectin	JJ	B-NP
column	column	NN	I-NP
[	[	-LRB-	0
27	27	CD	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
Consistent	Consistent	JJ	0
with	with	IN	0
these	these	DT	0
earlier	earlier	JJR	0
studies	studies	NNS	0
,	,	,	0
rat	rat	NN	B-NP
aortic	aortic	NN	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
cell	cell	NN	I-NP
surface	surface	NN	I-NP
radioiodination	radioiodination	NN	I-NP
followed	followed	VBD	0
by	by	IN	0
affinity	affinity	JJ	B-NP
chromatography	chromatography	NN	I-NP
on	on	IN	0
fibronectin	fibronectin	JJ	B-NP
Sepharose	Sepharose	NNP	I-NP
and	and	CC	0
elution	elution	NN	B-NP
with	with	IN	0
EDTA	EDTA	NNP	B-NP
revealed	revealed	VBD	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
two	two	CD	0
major	major	JJ	0
bands	bands	NNS	0
at	at	IN	0
120	120	CD	0
kDa	kDa	JJ	0
and	and	CC	0
140	140	CD	0
kDum	kDum	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
,	,	,	0
Elane	Elane	NNP	0
under	under	IN	0
FN	FN	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
sizes	sizes	NNS	0
match	match	VBP	0
those	those	DT	0
of	of	IN	0
the	the	DT	0
β1	β1	NNP	0
and	and	CC	0
α5	α5	CD	0
integrin	integrin	JJ	0
submits	submits	NN	0
,	,	,	0
respectively	respectively	RB	0
,	,	,	0
that	that	WDT	0
have	have	VBP	0
been	been	VBN	0
shown	shown	VBN	0
by	by	IN	0
affinity	affinity	JJ	B-NP
chromatography	chromatography	NN	I-NP
to	to	TO	0
bind	bind	VB	0
to	to	TO	0
the	the	DT	0
cell	cell	NN	0
binding	binding	JJ	0
domain	domain	NN	0
(	(	-LRB-	0
i.e.	i.e.	FW	0
,	,	,	0
10	10	CD	0
thtype	thtype	JJ	0
III	III	NNP	0
repeat	repeat	NN	0
)	)	-RRB-	0
of	of	IN	0
fibronectin	fibronectin	NN	B-NP
[	[	-LRB-	0
27	27	CD	0
28	28	CD	0
29	29	CD	0
30	30	CD	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Affinity	Affinity	JJ	B-NP
chromatography	chromatography	NN	I-NP
on	on	IN	0
a	a	DT	0
III1-C	III1-C	NNP	B-NP
Sepharose	Sepharose	NNP	I-NP
column	column	NN	I-NP
revealed	revealed	VBD	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
three	three	CD	0
major	major	JJ	0
bands	bands	NNS	0
of	of	IN	0
sizes	sizes	CD	0
120	120	CD	0
kDa	kDa	NN	B-NP
,	,	,	0
140	140	CD	0
kDa	kDa	JJ	0
and	and	CC	0
150	150	CD	0
kDum	kDum	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
,	,	,	0
Elane	Elane	NNP	0
under	under	IN	0
C	C	NNP	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
120	120	CD	0
kDa	kDa	JJ	0
and	and	CC	0
140	140	CD	0
kda	kda	NN	B-NP
band	band	NN	I-NP
likely	likely	RB	0
represent	represent	VB	0
the	the	DT	0
β1	β1	NNP	0
and	and	CC	0
α5	α5	CD	0
subunits	subunits	NNS	0
(	(	-LRB-	0
as	as	IN	0
above	above	JJ	0
)	)	-RRB-	0
,	,	,	0
while	while	IN	0
the	the	DT	0
150	150	CD	0
kDa	kDa	JJ	B-NP
band	band	NN	I-NP
may	may	MD	0
represent	represent	VB	0
either	either	RB	0
the	the	DT	0
α2	α2	NNP	0
or	or	CC	0
α3	α3	CD	0
integrin	integrin	JJ	0
subunits	subunits	NN	0
,	,	,	0
which	which	WDT	0
are	are	VBP	0
known	known	VBN	0
to	to	TO	0
be	be	VB	0
expressed	expressed	VBN	0
by	by	IN	0
vsmc	vsmc	NN	B-NP
[	[	-LRB-	0
26	26	CD	0
]	]	-RRB-	0
.	.	.	0
Affinity	Affinity	JJ	B-NP
chromatography	chromatography	NN	I-NP
on	on	IN	0
the	the	DT	0
control	control	NN	0
III	III	NNP	0
11-C	11-C	NNP	0
column	column	NN	0
yielded	yielded	VBD	0
no	no	DT	0
radioiodinated	radioiodinated	JJ	B-NP
protein	protein	NN	I-NP
that	that	WDT	0
were	were	VBD	0
eluted	eluted	VBN	0
from	from	IN	0
the	the	DT	0
column	column	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
,	,	,	0
Elane	Elane	NNP	0
under	under	IN	0
11C	11C	CD	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
are	are	VBP	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
hypothesis	hypothesis	NN	0
that	that	IN	0
one	one	CD	0
or	or	CC	0
more	more	RBR	0
pi	pi	JJ	0
integrins	integrins	JJ	B-NP
act	act	NN	I-NP
as	as	IN	0
iii1-c	iii1-c	NN	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
Taken	Taken	VBN	0
together	together	RP	0
with	with	IN	0
the	the	DT	0
integrin-blocking	integrin-blocking	JJ	B-NP
result	result	NN	I-NP
described	described	VBD	0
above	above	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
clear	clear	JJ	0
that	that	IN	0
RASMC	RASMC	NNP	B-NP
adhesion	adhesion	VBD	I-NP
to	to	TO	0
III1-C	III1-C	NNP	B-NP
is	is	VBZ	0
partially	partially	RB	0
mediated	mediated	VBN	0
through	through	IN	0
β1	β1	CD	0
integrins	integrins	NNS	0
.	.	.	0
Cell	Cell	NN	B-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
activates	activates	CD	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
integrin	integrin	NN	B-NP
are	are	VBP	0
known	known	VBN	0
to	to	TO	0
activate	activate	VB	0
signaling	signaling	VBG	B-NP
pathway	pathway	NN	I-NP
in	in	IN	0
cells	cells	NNS	0
[	[	-LRB-	0
32	32	CD	0
33	33	CD	0
34	34	CD	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
Among	Among	IN	0
the	the	DT	0
most	most	RBS	0
well-studied	well-studied	JJ	0
signaling	signaling	JJ	0
pathways	pathways	NN	0
is	is	VBZ	0
the	the	DT	0
Ras	Ras	NNP	B-NP
/	/	NNP	I-NP
MAPK	MAPK	NNP	I-NP
pathway	pathway	VBZ	I-NP
leading	leading	VBG	0
to	to	TO	0
erk1	erk1	NN	B-NP
activation	activation	VB	I-NP
and	and	CC	0
ERK2	ERK2	NNP	B-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
therefore	therefore	RB	0
decided	decided	VBN	0
to	to	TO	0
test	test	VB	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
on	on	IN	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
.	.	.	0
As	As	RB	0
expected	expected	VBN	0
,	,	,	0
treatment	treatment	NN	0
of	of	IN	0
RASMCs	RASMCs	JJ	0
with	with	IN	0
PDGF	PDGF	NNP	B-NP
resulted	resulted	VBD	0
in	in	IN	0
erk1	erk1	NN	B-NP
activation	activation	NN	I-NP
/	/	CD	0
2	2	CD	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
,	,	,	0
pdgf	pdgf	NN	B-NP
lane	lane	NN	I-NP
)	)	-RRB-	0
.	.	.	0
plating	plating	NN	B-NP
rasmc	rasmc	NN	I-NP
onto	onto	IN	0
a	a	DT	0
fibronectin	fibronectin	JJ	B-NP
coated	coated	JJ	I-NP
dish	dish	NN	I-NP
in	in	IN	0
the	the	DT	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
absence	absence	NN	I-NP
yielded	yielded	VBD	0
moderate	moderate	JJ	0
erk1	erk1	NN	B-NP
activation	activation	NN	I-NP
/	/	CD	0
2	2	CD	0
,	,	,	0
which	which	WDT	0
peaked	peaked	VBD	0
at	at	IN	0
30	30	CD	0
min	min	NN	B-NP
then	then	RB	0
decreased	decreased	VBD	0
somewhat	somewhat	RB	0
over	over	IN	0
the	the	DT	0
next	next	JJ	0
30	30	CD	0
min	min	NN	B-NP
of	of	IN	0
the	the	DT	0
experiment	experiment	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
,	,	,	0
bottom	bottom	JJ	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
plating	plating	JJ	0
cells	cells	NNS	0
onto	onto	IN	0
a	a	DT	0
III1-C	III1-C	JJ	B-NP
coated	coated	JJ	0
dish	dish	NN	0
gave	gave	VBD	0
strong	strong	JJ	0
erk1	erk1	NN	B-NP
activation	activation	NN	I-NP
/	/	CD	0
2	2	CD	0
,	,	,	0
which	which	WDT	0
peaked	peaked	VBD	0
at	at	IN	0
30	30	CD	0
min	min	NN	B-NP
and	and	CC	0
remained	remained	VBD	0
relatively	relatively	RB	0
constant	constant	JJ	0
for	for	IN	0
the	the	DT	0
subsequent	subsequent	JJ	0
30	30	CD	0
min	min	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
,	,	,	0
top	top	JJ	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
control	control	NN	B-NP
protein	protein	NN	I-NP
III	III	NNP	I-NP
11-C	11-C	NNP	0
did	did	VBD	0
not	not	RB	0
appreciably	appreciably	RB	0
stimulate	stimulate	VB	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
phosphorylation	phosphorylation	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
,	,	,	0
11C	11C	CD	0
lanes	lanes	NNS	0
,	,	,	0
both	both	DT	0
panels	panels	NNS	0
)	)	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
the	the	DT	0
adhesion	adhesion	NN	B-NP
of	of	IN	0
RASMCs	RASMCs	JJ	0
to	to	TO	0
III1-C	III1-C	NNP	B-NP
resulted	resulted	VBD	0
in	in	IN	0
robust	robust	JJ	0
erk1	erk1	NN	B-NP
activation	activation	NN	I-NP
/	/	CD	0
2	2	CD	0
that	that	WDT	0
was	was	VBD	0
comparable	comparable	JJ	0
to	to	TO	0
the	the	DT	0
activation	activation	NN	B-NP
obtained	obtained	VBN	0
with	with	IN	0
PDGF	PDGF	NNP	B-NP
.	.	.	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
by	by	IN	0
III1-C	III1-C	NNP	B-NP
is	is	VBZ	0
dependent	dependent	JJ	0
on	on	IN	0
β1	β1	CD	0
integrins	integrins	NN	0
As	As	IN	0
shown	shown	VBN	0
above	above	IN	0
,	,	,	0
several	several	JJ	0
agents	agents	NNS	0
that	that	IN	0
block	block	NN	0
β1	β1	CD	0
integrin	integrin	NNS	0
function	function	VBP	0
partially	partially	RB	0
inhibit	inhibit	VB	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
.	.	.	0
We	We	PRP	0
therefore	therefore	RB	0
tested	tested	VBN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
these	these	DT	0
agents	agents	NNS	0
on	on	IN	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
by	by	IN	0
III1-C	III1-C	CD	B-NP
.	.	.	0
The	The	DT	0
results	results	NNS	0
obtained	obtained	VBN	0
with	with	IN	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
closely	closely	RB	0
paralleled	paralleled	VB	0
the	the	DT	0
results	results	NNS	0
obtained	obtained	VBN	0
with	with	IN	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
,	,	,	0
except	except	IN	0
that	that	IN	0
the	the	DT	0
individual	individual	JJ	0
blocking	blocking	VBG	B-NP
agent	agent	NN	I-NP
were	were	VBD	0
relatively	relatively	RB	0
more	more	RBR	0
efficient	efficient	JJ	0
at	at	IN	0
inhibiting	inhibiting	CD	B-NP
ERK1	ERK1	CD	I-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
heparin	heparin	NN	B-NP
,	,	,	0
EDTA	EDTA	NNP	B-NP
,	,	,	0
anti-β1	anti-β1	NNP	B-NP
mAb	mAb	NNP	I-NP
and	and	CC	0
RGD	RGD	NNP	B-NP
peptide	peptide	VBD	0
all	all	DT	0
significantly	significantly	RB	0
inhibited	inhibited	VBD	B-NP
ERK1	ERK1	CD	I-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
by	by	IN	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
Heparin	Heparin	NNP	B-NP
was	was	VBD	0
most	most	RBS	0
effective	effective	JJ	0
and	and	CC	0
completely	completely	RB	0
blocked	blocked	VBD	B-NP
ERK1	ERK1	CD	I-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
.	.	.	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
the	the	DT	0
negative	negative	JJ	B-NP
control	control	NN	I-NP
RAD	RAD	NNP	I-NP
peptide	peptide	NN	I-NP
did	did	VBD	0
not	not	RB	0
inhibit	inhibit	VB	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
by	by	IN	0
III1-C	III1-C	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
6	6	CD	0
,	,	,	0
C+RAD	C+RAD	CD	0
lane	lane	CD	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
both	both	DT	0
integrin	integrin	NN	B-NP
and	and	CC	0
the	the	DT	0
class	class	NN	0
of	of	IN	0
receptors	receptors	JJ	B-NP
inhibited	inhibited	NN	I-NP
by	by	IN	0
heparin	heparin	NN	B-NP
were	were	VBD	0
required	required	VBN	0
for	for	IN	0
III1-C	III1-C	CD	B-NP
mediated	mediated	JJ	0
erk1	erk1	NN	B-NP
activation	activation	NN	I-NP
/	/	CD	0
2	2	CD	0
.	.	.	0
Role	Role	NN	0
of	of	IN	0
heparan	heparan	JJ	B-NP
sulfate	sulfate	JJ	I-NP
proteoglycan	proteoglycan	NN	I-NP
in	in	IN	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
and	and	CC	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
by	by	IN	0
III1-C	III1-C	CD	B-NP
Because	Because	IN	0
heparin	heparin	NN	B-NP
was	was	VBD	0
able	able	JJ	0
to	to	TO	0
inhibit	inhibit	VB	0
the	the	DT	0
attachment	attachment	NN	0
of	of	IN	0
cells	cells	NNS	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
and	and	CC	0
the	the	DT	0
erk1	erk1	NN	B-NP
activation	activation	NN	I-NP
/	/	CD	0
2	2	CD	0
by	by	IN	0
III1-C	III1-C	NNP	B-NP
,	,	,	0
we	we	PRP	0
tested	tested	VBD	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
other	other	JJ	0
glycosaminoglycan	glycosaminoglycan	NN	B-NP
on	on	IN	0
stimulated	stimulated	CD	B-NP
erk1	erk1	NN	I-NP
iii1-c	iii1-c	NN	I-NP
/	/	CD	0
2	2	CD	0
activity	activity	NN	0
.	.	.	0
Heparin	Heparin	NNP	B-NP
,	,	,	0
heparan	heparan	JJ	B-NP
sulfate	sulfate	NN	I-NP
and	and	CC	0
blocked	blocked	VBD	B-NP
erk1	erk1	NN	I-NP
dermatan	dermatan	JJ	I-NP
sulfate	sulfate	NN	I-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
by	by	IN	0
III1-C	III1-C	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
7	7	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
hyaluronic	hyaluronic	JJ	B-NP
acid	acid	NN	I-NP
,	,	,	0
chondroitin-4-sulfate	chondroitin-4-sulfate	NNP	B-NP
and	and	CC	0
chondroitin-6-sulfate	chondroitin-6-sulfate	NNP	B-NP
had	had	VBD	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
the	the	DT	0
iii1-c	iii1-c	NN	B-NP
ability	ability	NN	I-NP
to	to	TO	0
stimulate	stimulate	VB	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activity	activity	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
7	7	CD	0
)	)	-RRB-	0
or	or	CC	0
on	on	IN	0
the	the	DT	0
adhesion	adhesion	NN	B-NP
of	of	IN	0
cells	cells	NNS	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
heparin	heparin	NN	B-NP
,	,	,	0
heparan	heparan	JJ	B-NP
sulfate	sulfate	NN	I-NP
and	and	CC	0
dermatan	dermatan	NN	B-NP
sulfate	sulfate	NN	I-NP
inhibit	inhibit	FW	0
mediated	mediated	VBN	B-NP
cell	cell	NN	I-NP
adhesion	adhesion	NN	I-NP
iii1-c	iii1-c	NN	I-NP
and	and	CC	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activation	activation	CD	B-NP
due	due	JJ	0
to	to	TO	0
common	common	JJ	0
chemical	chemical	NN	B-NP
feature	feature	NN	I-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
heparin	heparin	NN	B-NP
,	,	,	0
heparan	heparan	JJ	B-NP
sulfate	sulfate	NN	I-NP
,	,	,	0
and	and	CC	0
dermatan	dermatan	NN	B-NP
sulfate	sulfate	NN	I-NP
all	all	FW	0
contain	contain	FW	0
iduronic	iduronic	NN	B-NP
acid	acid	JJ	I-NP
residue	residue	NN	I-NP
whereas	whereas	FW	0
chondroitin	chondroitin	NN	B-NP
sulfate	sulfate	NN	I-NP
and	and	CC	0
hyaluronic	hyaluronic	JJ	B-NP
acid	acid	NN	I-NP
do	do	VBP	0
not	not	RB	0
.	.	.	0
The	The	DT	0
results	results	NNS	0
presented	presented	VBD	0
above	above	RB	0
indicate	indicate	VB	0
that	that	IN	0
a	a	DT	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
proteoglycan	proteoglycan	NN	I-NP
(	(	-LRB-	0
HSPG	HSPG	NNP	B-NP
)	)	-RRB-	0
or	or	CC	0
dermatan	dermatan	JJ	B-NP
sulfate	sulfate	JJ	I-NP
proteoglycan	proteoglycan	NN	I-NP
on	on	IN	0
the	the	DT	0
surface	surface	NN	0
of	of	IN	0
rat	rat	NN	B-NP
aortic	aortic	NN	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
may	may	MD	0
serve	serve	VB	0
as	as	IN	0
a	a	DT	0
iii1-c	iii1-c	NN	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
To	To	TO	0
further	further	RB	0
explore	explore	VB	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
a	a	DT	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
proteoglycan	proteoglycan	NN	I-NP
serves	serves	VBZ	0
as	as	IN	0
a	a	DT	0
iii1-c	iii1-c	NN	B-NP
receptor	receptor	NN	I-NP
,	,	,	0
rat	rat	NN	B-NP
aortic	aortic	NN	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
the	the	DT	0
glycosaminoglycan-degrading	glycosaminoglycan-degrading	JJ	B-NP
enzyme	enzyme	NN	I-NP
seeded	seeded	NN	0
onto	onto	IN	0
III1-C	III1-C	NNP	B-NP
,	,	,	0
and	and	CC	0
analyzed	analyzed	VBD	0
for	for	IN	0
the	the	DT	0
erk1	erk1	NN	B-NP
activation	activation	NN	I-NP
/	/	CD	0
2	2	CD	0
.	.	.	0
Heparitinase	Heparitinase	JJ	B-NP
treatment	treatment	NN	I-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
chondroitinase	chondroitinase	JJ	B-NP
ABC	ABC	NNP	I-NP
treatment	treatment	NN	I-NP
decreased	decreased	VBD	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
by	by	IN	0
III1-C	III1-C	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
8	8	CD	0
)	)	-RRB-	0
.	.	.	0
Heparitinase	Heparitinase	JJ	B-NP
treatment	treatment	NN	I-NP
also	also	RB	0
inhibited	inhibited	JJ	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
by	by	IN	0
25-40	25-40	CD	0
%	%	NN	0
,	,	,	0
while	while	IN	0
chondroitinase	chondroitinase	JJ	B-NP
ABC	ABC	NNP	I-NP
treatment	treatment	NN	I-NP
did	did	VBD	0
not	not	RB	0
inhibit	inhibit	VB	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
result	result	NN	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
idea	idea	NN	0
that	that	IN	0
HSPGs	HSPGs	JJ	0
but	but	CC	0
not	not	RB	0
chondroitin	chondroitin	JJ	B-NP
sulfate	sulfate	JJ	I-NP
proteoglycan	proteoglycan	NN	I-NP
serve	serve	VBP	0
as	as	RB	0
iii1-c	iii1-c	NN	B-NP
signaling	signaling	VBG	I-NP
receptor	receptor	NN	I-NP
.	.	.	0
To	To	TO	0
identify	identify	VB	0
the	the	DT	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
proteoglycan	proteoglycan	NN	I-NP
that	that	WDT	0
may	may	MD	0
serve	serve	VB	0
as	as	IN	0
iii1-c	iii1-c	NN	B-NP
receptor	receptor	NN	I-NP
,	,	,	0
rat	rat	NN	B-NP
aortic	aortic	NN	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
labeled	labeled	VBN	0
with	with	IN	0
35SO	35SO	CD	0
4	4	CD	0
and	and	CC	0
cell	cell	NN	B-NP
lysate	lysate	NN	I-NP
were	were	VBD	0
applied	applied	VBN	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
and	and	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
columns	columns	NNS	0
.	.	.	0
The	The	DT	0
most	most	RBS	0
highly	highly	RB	0
labeled	labeled	VBN	B-NP
band	band	NN	I-NP
,	,	,	0
migrating	migrating	VBG	0
in	in	IN	0
a	a	DT	0
smear	smear	NN	0
at	at	IN	0
about	about	IN	0
450	450	CD	0
kDa	kDa	NN	B-NP
,	,	,	0
bound	bound	VBN	0
efficiently	efficiently	RB	0
to	to	TO	0
the	the	DT	0
III1-C	III1-C	JJ	B-NP
column	column	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
9A	9A	NNP	0
,	,	,	0
compare	compare	JJ	0
flow	flow	NN	0
through	through	IN	0
and	and	CC	0
elution	elution	JJ	B-NP
lane	lane	NN	I-NP
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
proteoglycan	proteoglycan	NN	B-NP
resisted	resisted	VBD	0
elution	elution	VBN	0
by	by	IN	0
8	8	CD	0
M	M	NNP	0
urea	urea	NN	B-NP
but	but	CC	0
was	was	VBD	0
eluted	eluted	VBN	0
by	by	IN	0
boiling	boiling	VBG	0
the	the	DT	0
sepharose	sepharose	NN	B-NP
bead	bead	NN	I-NP
in	in	IN	0
sd	sd	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
9A	9A	NNP	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
same	same	JJ	0
proteoglycan	proteoglycan	NN	B-NP
did	did	VBD	0
not	not	RB	0
bind	bind	JJ	0
appreciably	appreciably	NN	0
to	to	TO	0
the	the	DT	0
III	III	NNP	0
11-C	11-C	NNP	0
column	column	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
9A	9A	NNP	0
)	)	-RRB-	0
.	.	.	0
Heparitinase	Heparitinase	NNP	B-NP
and	and	CC	0
chondroitinase	chondroitinase	JJ	B-NP
ABC	ABC	NNP	I-NP
treatment	treatment	NN	I-NP
of	of	IN	0
the	the	DT	0
35SO	35SO	CD	0
4	4	CD	0
labeled	labeled	CD	0
samples	samples	NNS	0
revealed	revealed	VBD	0
that	that	IN	0
the	the	DT	0
450	450	CD	0
kDa	kDa	JJ	B-NP
proteoglycan	proteoglycan	NN	I-NP
was	was	VBD	0
composed	composed	VBN	0
mostly	mostly	RB	0
of	of	IN	0
hspg	hspg	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
9B	9B	NNP	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
most	most	JJS	0
of	of	IN	0
the	the	DT	0
rat	rat	NN	B-NP
aortic	aortic	NN	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
cell	cell	NN	I-NP
surface	surface	NN	I-NP
hspg	hspg	NN	I-NP
can	can	MD	0
bind	bind	VB	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
in	in	IN	0
affinity	affinity	JJ	B-NP
chromatography	chromatography	NN	I-NP
.	.	.	0
rasmc	rasmc	NN	B-NP
hspg	hspg	NN	I-NP
were	were	VBD	0
analyzed	analyzed	VBN	0
further	further	RBR	0
by	by	IN	0
immunoblotting	immunoblotting	NN	B-NP
with	with	IN	0
the	the	DT	0
monoclonal	monoclonal	JJ	B-NP
antibody	antibody	NN	I-NP
3G10	3G10	NN	I-NP
which	which	WDT	0
specifically	specifically	RB	0
recognizes	recognizes	VBZ	0
desaturated	desaturated	JJ	B-NP
uronate	uronate	NN	I-NP
on	on	IN	0
the	the	DT	0
heparan	heparan	JJ	B-NP
sulfate	sulfate	JJ	I-NP
stub	stub	NN	I-NP
that	that	WDT	0
remain	remain	VBP	0
associated	associated	VBN	0
with	with	IN	0
core	core	JJ	0
proteins	proteins	NNS	0
after	after	IN	0
heparitinase	heparitinase	JJ	B-NP
digestion	digestion	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
rasmc	rasmc	NN	B-NP
lysate	lysate	NN	I-NP
complete	complete	JJ	I-NP
digestion	digestion	NN	I-NP
with	with	IN	0
heparitinase	heparitinase	NN	B-NP
reveals	reveals	VBZ	0
major	major	JJ	0
bands	bands	NNS	0
at	at	IN	0
46	46	CD	0
kDa	kDa	JJ	0
and	and	CC	0
70	70	CD	0
kDa	kDa	NN	B-NP
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
these	these	DT	0
are	are	VBP	0
the	the	DT	0
sizes	sizes	NN	0
of	of	IN	0
the	the	DT	0
major	major	JJ	0
hspg	hspg	NN	B-NP
core	core	NN	I-NP
protein	protein	NN	I-NP
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
rasmc	rasmc	NN	B-NP
lysate	lysate	NN	I-NP
were	were	VBD	0
subjected	subjected	VBN	0
to	to	TO	0
partial	partial	JJ	0
heparitinase	heparitinase	JJ	B-NP
treatment	treatment	NN	I-NP
(	(	-LRB-	0
full	full	JJ	0
digestion	digestion	NN	0
was	was	VBD	0
not	not	RB	0
performed	performed	VBN	0
in	in	IN	0
order	order	NN	0
to	to	TO	0
allow	allow	VB	0
some	some	DT	0
GAGs	GAGs	JJ	0
to	to	TO	0
remain	remain	VB	0
associated	associated	VBN	0
with	with	IN	0
the	the	DT	0
core	core	NN	0
proteins	proteins	NNS	0
)	)	-RRB-	0
then	then	RB	0
applied	applied	VBN	0
to	to	TO	0
either	either	DT	0
III1-C	III1-C	NNP	B-NP
or	or	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
Sepharose	Sepharose	NNP	0
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
10	10	CD	0
,	,	,	0
most	most	JJS	0
of	of	IN	0
the	the	DT	0
46	46	CD	0
kDa	kDa	JJ	0
and	and	CC	0
70	70	CD	0
kda	kda	NN	B-NP
hspg	hspg	NN	I-NP
bound	bound	VBN	0
to	to	TO	0
III1-C	III1-C	NNP	B-NP
Sepharose	Sepharose	NNP	I-NP
but	but	CC	0
not	not	RB	0
to	to	TO	0
III	III	NNP	0
11-C	11-C	NNP	0
Sepharose	Sepharose	NNP	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
heparin	heparin	NN	B-NP
in	in	IN	0
the	the	DT	0
lysate	lysate	NN	B-NP
inhibited	inhibited	VBD	0
the	the	DT	0
46	46	CD	0
kDa	kDa	JJ	0
and	and	CC	0
70	70	CD	0
kda	kda	NN	B-NP
hspg	hspg	NN	I-NP
from	from	IN	0
binding	binding	VBG	0
to	to	TO	0
the	the	DT	0
III1-C	III1-C	JJ	B-NP
column	column	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
10	10	CD	0
,	,	,	0
compare	compare	VBP	0
C	C	NNP	0
and	and	CC	0
C•H	C•H	CD	0
lanes	lanes	NNS	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
46	46	CD	0
kDa	kDa	JJ	0
and	and	CC	0
70	70	CD	0
kDa	kDa	JJ	B-NP
binding	binding	NN	I-NP
to	to	TO	0
III1-C	III1-C	CD	B-NP
by	by	IN	0
heparin	heparin	NN	B-NP
suggests	suggests	VBZ	0
that	that	IN	0
these	these	DT	0
hspg	hspg	NN	B-NP
may	may	MD	0
serve	serve	VB	0
as	as	IN	0
iii1-c	iii1-c	NN	B-NP
receptor	receptor	NN	I-NP
in	in	IN	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
and	and	CC	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
signaling	signaling	NNS	0
.	.	.	0
Discussion	Discussion	NN	0
We	We	PRP	0
have	have	VBP	0
found	found	VBN	0
that	that	IN	0
cells	cells	NNS	0
can	can	MD	0
interact	interact	VB	0
with	with	IN	0
a	a	DT	0
portion	portion	NN	0
of	of	IN	0
the	the	DT	0
fibronectin	fibronectin	JJ	0
first	first	JJ	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
,	,	,	0
leading	leading	VBG	0
to	to	TO	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
and	and	CC	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
activation	activation	NN	I-NP
,	,	,	0
and	and	CC	0
that	that	IN	0
this	this	DT	0
signaling	signaling	NN	0
requires	requires	VBZ	0
both	both	DT	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
hspg	hspg	NN	I-NP
and	and	CC	0
integrin	integrin	NN	B-NP
.	.	.	0
rat	rat	NN	B-NP
aortic	aortic	NN	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
are	are	VBP	0
able	able	JJ	0
to	to	TO	0
adhere	adhere	VB	0
to	to	TO	0
and	and	CC	0
spread	spread	NN	0
on	on	IN	0
III1-C	III1-C	CD	B-NP
.	.	.	0
Adhesion	Adhesion	JJ	B-NP
to	to	TO	0
iii1-c	iii1-c	NN	B-NP
result	result	NN	I-NP
in	in	IN	0
robust	robust	JJ	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
activation	activation	NN	I-NP
;	;	:	0
comparable	comparable	JJ	0
to	to	TO	0
that	that	DT	0
seen	seen	VBN	0
with	with	IN	0
PDGF	PDGF	NNP	B-NP
stimulation	stimulation	NN	I-NP
.	.	.	0
Several	Several	JJ	0
independent	independent	JJ	0
lines	lines	NNS	0
of	of	IN	0
evidence	evidence	NN	0
indicate	indicate	VBP	0
that	that	DT	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
hspg	hspg	NN	I-NP
and	and	CC	0
β1	β1	CD	0
integrins	integrins	JJ	0
act	act	NN	0
as	as	IN	0
iii1-c	iii1-c	NN	B-NP
receptor	receptor	NN	I-NP
and	and	CC	0
are	are	VBP	0
required	required	VBN	0
for	for	IN	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
and	and	CC	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
by	by	IN	0
III1-C	III1-C	CD	B-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
various	various	JJ	0
β1	β1	NN	0
integrin	integrin	VBZ	0
blocking	blocking	VBG	B-NP
agent	agent	NN	I-NP
inhibit	inhibit	VBP	0
cell	cell	NN	0
attachment	attachment	NN	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
and	and	CC	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
by	by	IN	0
III1-C	III1-C	CD	B-NP
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
inhibition	inhibition	VBG	0
by	by	IN	0
heparin	heparin	NN	B-NP
,	,	,	0
heparan-sulfate	heparan-sulfate	NNP	B-NP
,	,	,	0
and	and	CC	0
heparitinase	heparitinase	NN	B-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
by	by	IN	0
chondroitin	chondroitin	JJ	B-NP
sulfate	sulfate	NN	I-NP
or	or	CC	0
chondroitinase	chondroitinase	JJ	B-NP
ABC	ABC	NNP	I-NP
all	all	DT	0
point	point	NN	0
to	to	TO	0
the	the	DT	0
importance	importance	NN	0
of	of	IN	0
HSPGs	HSPGs	JJ	0
as	as	IN	0
receptor	receptor	NN	B-NP
.	.	.	0
Affinity	Affinity	JJ	B-NP
chromatography	chromatography	NN	I-NP
with	with	IN	0
125I	125I	CD	0
surface	surface	NN	0
labeled	labeled	VBN	0
proteins	proteins	NNS	0
resulted	resulted	VBD	0
in	in	IN	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
proteins	proteins	NNS	0
of	of	IN	0
the	the	DT	0
appropriate	appropriate	JJ	0
sizes	sizes	NNS	0
of	of	IN	0
β1	β1	CD	0
integrins	integrins	NN	0
to	to	TO	0
both	both	DT	0
FN	FN	NNP	B-NP
and	and	CC	0
iii1-c	iii1-c	NN	B-NP
column	column	NN	I-NP
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
affinity	affinity	JJ	B-NP
chromatography	chromatography	NN	I-NP
with	with	IN	0
35SO	35SO	CD	0
4	4	CD	0
-labeled	-labeled	JJ	0
cells	cells	NNS	0
suggests	suggests	VBZ	0
that	that	DT	0
HSPGs	HSPGs	JJ	0
with	with	IN	0
core	core	JJ	0
protein	protein	NN	0
sizes	sizes	NNS	0
of	of	IN	0
46	46	CD	0
kDa	kDa	JJ	0
and	and	CC	0
70	70	CD	0
kDum	kDum	NN	B-NP
serve	serve	VBP	0
as	as	IN	0
iii1-c	iii1-c	NN	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
Taken	Taken	VBN	0
together	together	RB	0
,	,	,	0
these	these	DT	0
results	results	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
the	the	DT	0
first	first	JJ	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
of	of	IN	0
fibronectin	fibronectin	NN	B-NP
can	can	MD	0
serve	serve	VB	0
as	as	IN	0
a	a	DT	0
cell	cell	NN	0
binding	binding	JJ	0
domain	domain	NN	0
and	and	CC	0
that	that	IN	0
both	both	DT	0
integrin	integrin	NN	B-NP
and	and	CC	0
cell	cell	NN	0
surface	surface	NN	0
HSPGs	HSPGs	JJ	B-NP
function	function	NN	I-NP
as	as	IN	0
receptor	receptor	NN	B-NP
for	for	IN	0
this	this	DT	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
.	.	.	0
Our	Our	PRP$	0
results	results	NNS	0
demonstrate	demonstrate	VBP	0
that	that	IN	0
both	both	DT	0
integrin	integrin	NN	B-NP
and	and	CC	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
hspg	hspg	NN	I-NP
are	are	VBP	0
required	required	VBN	0
for	for	IN	0
robust	robust	JJ	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
1	1	CD	0
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
when	when	WRB	0
cells	cells	NNS	0
adhere	adhere	VBP	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
are	are	VBP	0
one	one	CD	0
of	of	IN	0
the	the	DT	0
first	first	JJ	0
demonstration	demonstration	NN	B-NP
that	that	IN	0
hspg	hspg	NN	B-NP
can	can	MD	0
activate	activate	VB	0
the	the	DT	0
signaling	signaling	VBG	B-NP
pathway	pathway	NNS	I-NP
extracellular	extracellular	NN	I-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
.	.	.	0
Another	Another	DT	0
example	example	NN	0
of	of	IN	0
this	this	DT	0
closely	closely	RB	0
parallels	parallels	VBZ	0
our	our	PRP$	0
findings	findings	NNS	0
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
jurkat	jurkat	NN	B-NP
t	t	NN	I-NP
cell	cell	NN	I-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
thrombospondin-1	thrombospondin-1	NNP	B-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
require	require	VB	0
the	the	DT	0
cooperation	cooperation	NN	0
of	of	IN	0
three	three	CD	0
classes	classes	NNS	0
of	of	IN	0
receptor	receptor	NN	B-NP
;	;	:	0
β1	β1	CD	0
integrins	integrins	NN	0
,	,	,	0
CD47	CD47	NNP	B-NP
and	and	CC	0
hspg	hspg	NN	B-NP
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
jurkat	jurkat	NN	B-NP
t	t	NN	I-NP
cell	cell	NN	I-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
thrombospondin-1	thrombospondin-1	CD	B-NP
stimulates	stimulates	CD	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
and	and	CC	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
HSPGs	HSPGs	JJ	0
to	to	TO	0
thrombospondin-1	thrombospondin-1	NNP	B-NP
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
this	this	DT	0
signaling	signaling	NN	0
.	.	.	0
The	The	DT	0
particular	particular	JJ	0
hspg	hspg	NN	B-NP
that	that	IN	0
mediate	mediate	CD	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
in	in	IN	0
jurkat	jurkat	NN	B-NP
t	t	NN	I-NP
cell	cell	NN	I-NP
have	have	VBP	0
not	not	RB	0
been	been	VBN	0
identified	identified	VBN	0
,	,	,	0
however	however	RB	0
,	,	,	0
the	the	DT	0
authors	authors	NNS	0
speculate	speculate	VBP	0
that	that	DT	0
syndecan	syndecan	NN	B-NP
may	may	MD	0
participate	participate	VB	0
in	in	IN	0
the	the	DT	0
adhesion	adhesion	NN	B-NP
and	and	CC	0
signaling	signaling	VBG	0
in	in	IN	0
that	that	DT	0
system	system	NN	0
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
may	may	MD	0
also	also	RB	0
be	be	VB	0
the	the	DT	0
case	case	NN	0
in	in	IN	0
our	our	PRP$	0
system	system	NN	0
,	,	,	0
as	as	RB	0
described	described	VBN	0
below	below	RB	0
.	.	.	0
One	One	CD	0
major	major	JJ	0
family	family	NN	0
of	of	IN	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
hspg	hspg	NN	I-NP
is	is	VBZ	0
the	the	DT	0
syndecan	syndecan	JJ	B-NP
family	family	NN	I-NP
.	.	.	0
There	There	EX	0
are	are	VBP	0
4	4	CD	0
members	members	NNS	0
in	in	IN	0
the	the	DT	0
syndecan	syndecan	JJ	B-NP
family	family	NN	I-NP
(	(	-LRB-	0
syndecan-1	syndecan-1	NNP	B-NP
through-4	through-4	NNP	I-NP
)	)	-RRB-	0
[	[	-LRB-	0
39	39	CD	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
Syndecan-1	Syndecan-1	NNP	B-NP
,	,	,	0
-2	-2	NNP	0
and	and	CC	0
-4	-4	NNP	0
are	are	VBP	0
known	known	VBN	0
to	to	TO	0
bind	bind	VB	0
to	to	TO	0
extracellular	extracellular	VB	0
matrix	matrix	JJ	0
proteins	proteins	NNS	0
and	and	CC	0
syndecan-1	syndecan-1	NNP	B-NP
and	and	CC	0
-4	-4	NNP	0
have	have	VBP	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
support	support	VB	0
stress	stress	NN	B-NP
fiber	fiber	NN	I-NP
formation	formation	NN	I-NP
in	in	IN	0
conjunction	conjunction	NN	0
with	with	IN	0
integrin	integrin	NN	B-NP
[	[	-LRB-	0
41	41	CD	0
42	42	CD	0
43	43	CD	0
44	44	CD	0
45	45	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
HSPGs	HSPGs	JJ	0
we	we	PRP	0
have	have	VBP	0
identified	identified	VBN	0
as	as	IN	0
iii1-c	iii1-c	NN	B-NP
receptor	receptor	NN	I-NP
have	have	VBP	0
core	core	JJ	0
proteins	proteins	NNS	0
that	that	IN	0
migrate	migrate	NN	0
at	at	IN	0
the	the	DT	0
approximate	approximate	JJ	0
sizes	sizes	NNS	0
of	of	IN	0
syndecan-1	syndecan-1	NNP	B-NP
(	(	-LRB-	0
~69	~69	CD	0
kDa	kDa	JJ	B-NP
core	core	NN	I-NP
protein	protein	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
syndecan-2	syndecan-2	NNP	B-NP
(	(	-LRB-	0
~48	~48	CD	0
kDa	kDa	JJ	B-NP
core	core	NN	I-NP
protein	protein	NN	I-NP
)	)	-RRB-	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
therefore	therefore	RB	0
possible	possible	JJ	0
that	that	IN	0
our	our	PRP$	0
46	46	CD	0
kDa	kDa	JJ	0
and	and	CC	0
70	70	CD	0
kda	kda	NN	B-NP
hspg	hspg	NN	I-NP
represent	represent	VBP	0
syndecan	syndecan	JJ	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
.	.	.	0
As	As	RB	0
described	described	VBN	0
above	above	IN	0
,	,	,	0
the	the	DT	0
syndecan	syndecan	NN	B-NP
may	may	MD	0
cooperate	cooperate	VB	0
with	with	IN	0
β1	β1	CD	0
integrins	integrins	NNS	0
and	and	CC	0
CD47	CD47	CD	B-NP
to	to	TO	0
activate	activate	VB	0
the	the	DT	0
signaling	signaling	VBG	B-NP
pathway	pathway	NN	I-NP
extracellular	extracellular	NN	I-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
in	in	IN	0
t	t	NN	B-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
similar	similar	JJ	0
mechanism	mechanism	NN	0
may	may	MD	0
apply	apply	VB	0
to	to	TO	0
the	the	DT	0
adhesion	adhesion	NN	B-NP
of	of	IN	0
RASMCs	RASMCs	JJ	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
.	.	.	0
Future	Future	JJ	0
studies	studies	NNS	0
will	will	MD	0
determine	determine	VB	0
the	the	DT	0
identity	identity	NN	0
of	of	IN	0
the	the	DT	0
HSPGs	HSPGs	JJ	0
that	that	IN	0
act	act	NN	0
as	as	IN	0
iii1-c	iii1-c	NN	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
The	The	DT	0
Ras	Ras	NNP	B-NP
/	/	NNP	I-NP
MAPK	MAPK	NNP	I-NP
pathway	pathway	NN	I-NP
is	is	VBZ	0
typically	typically	RB	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
a	a	DT	0
part	part	NN	0
of	of	IN	0
a	a	DT	0
mitogenic	mitogenic	JJ	B-NP
pathway	pathway	NN	I-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
we	we	PRP	0
and	and	CC	0
others	others	NNS	0
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
prolonged	prolonged	JJ	0
treatment	treatment	NN	0
with	with	IN	0
III1-C	III1-C	NNP	B-NP
can	can	MD	0
inhibit	inhibit	VB	0
cell	cell	NN	0
proliferation	proliferation	NN	0
[	[	-LRB-	0
3	3	CD	0
4	4	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
here	here	RB	0
we	we	PRP	0
show	show	VBP	0
that	that	DT	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
to	to	TO	0
III1-C	III1-C	NNP	B-NP
can	can	MD	0
activate	activate	VB	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
.	.	.	0
One	One	CD	0
possible	possible	JJ	0
explanation	explanation	NN	0
for	for	IN	0
this	this	DT	0
apparent	apparent	JJ	0
discrepancy	discrepancy	NN	0
is	is	VBZ	0
that	that	IN	0
although	although	IN	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
are	are	VBP	0
often	often	RB	0
involved	involved	VBN	0
in	in	IN	0
mitogenesi	mitogenesi	NN	B-NP
,	,	,	0
in	in	IN	0
SMCs	SMCs	NNP	B-NP
ERK	ERK	NNP	I-NP
activation	activation	NN	I-NP
can	can	MD	0
lead	lead	VB	0
to	to	TO	0
inhibition	inhibition	VB	0
of	of	IN	0
proliferation	proliferation	NN	B-NP
[	[	-LRB-	0
46	46	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
occurs	occurs	NN	0
through	through	IN	0
pge	pge	NN	B-NP
erk-mediated	erk-mediated	NN	I-NP
stimulation	stimulation	NN	I-NP
2	2	CD	0
production	production	NN	0
,	,	,	0
which	which	WDT	0
then	then	RB	0
inhibits	inhibits	VB	0
the	the	DT	0
smooth	smooth	JJ	B-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
[	[	-LRB-	0
46	46	CD	0
]	]	-RRB-	0
.	.	.	0
further	further	JJ	B-NP
experiment	experiment	NN	I-NP
will	will	MD	0
determine	determine	VB	0
whether	whether	IN	0
RASMCs	RASMCs	JJ	B-NP
produce	produce	NN	I-NP
PGE	PGE	NNP	I-NP
2	2	CD	0
after	after	IN	0
treatment	treatment	NN	0
with	with	IN	0
III1-C	III1-C	CD	B-NP
.	.	.	0
Another	Another	DT	0
possibility	possibility	NN	0
is	is	VBZ	0
that	that	IN	0
III1-C	III1-C	CD	B-NP
stimulates	stimulates	CD	0
other	other	JJ	0
signaling	signaling	NNS	B-NP
pathway	pathway	NN	I-NP
apart	apart	RB	0
from	from	IN	0
the	the	DT	0
ERK	ERK	NNP	B-NP
pathway	pathway	NN	I-NP
,	,	,	0
and	and	CC	0
that	that	IN	0
one	one	CD	0
of	of	IN	0
the	the	DT	0
other	other	JJ	0
signaling	signaling	NNS	B-NP
pathway	pathway	NN	I-NP
inhibits	inhibits	JJ	0
proliferation	proliferation	NN	B-NP
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
.	.	.	0
The	The	DT	0
relationship	relationship	NN	B-NP
between	between	IN	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
,	,	,	0
stimulation	stimulation	NN	0
of	of	IN	0
other	other	JJ	0
signaling	signaling	JJ	0
pathways	pathways	NN	0
and	and	CC	0
growth	growth	NN	B-NP
inhibition	inhibition	NN	I-NP
by	by	IN	0
III1-C	III1-C	NNP	B-NP
will	will	MD	0
be	be	VB	0
elucidated	elucidated	VBN	0
by	by	IN	0
future	future	JJ	0
experiments	experiments	NNS	0
.	.	.	0
The	The	DT	0
III1-C	III1-C	JJ	B-NP
protein	protein	NN	I-NP
has	has	VBZ	0
recently	recently	RB	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
inhibit	inhibit	VB	0
angiogenesi	angiogenesi	NN	B-NP
,	,	,	0
tumor	tumor	NN	B-NP
growth	growth	NN	I-NP
and	and	CC	0
metastasi	metastasi	NN	B-NP
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Those	Those	DT	0
findings	findings	NNS	0
,	,	,	0
along	along	RB	0
with	with	IN	0
our	our	PRP$	0
present	present	JJ	0
findings	findings	NNS	0
reveal	reveal	VBP	0
some	some	DT	0
intriguing	intriguing	JJ	0
parallels	parallels	NNS	0
between	between	IN	0
III1-C	III1-C	NNP	B-NP
and	and	CC	0
the	the	DT	0
angiogenesi	angiogenesi	NN	B-NP
inhibitor	inhibitor	NN	I-NP
endostatin	endostatin	NN	I-NP
[	[	-LRB-	0
47	47	CD	0
]	]	-RRB-	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
both	both	DT	0
III1-C	III1-C	NNP	B-NP
and	and	CC	0
endostatin	endostatin	NN	B-NP
are	are	VBP	0
fragments	fragments	VBN	0
of	of	IN	0
matrix	matrix	JJ	0
proteins	proteins	NNS	0
and	and	CC	0
can	can	MD	0
inhibit	inhibit	VB	0
angiogenesi	angiogenesi	NN	B-NP
and	and	CC	0
tumor	tumor	NN	B-NP
growth	growth	NN	I-NP
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
recent	recent	JJ	0
work	work	NN	0
has	has	VBZ	0
shown	shown	VBN	0
that	that	IN	0
cells	cells	NNS	0
interact	interact	VBN	0
with	with	IN	0
endostatin	endostatin	NN	B-NP
through	through	IN	0
two	two	CD	0
classes	classes	NNS	0
of	of	IN	0
receptor	receptor	NN	B-NP
;	;	:	0
integrin	integrin	NN	B-NP
and	and	CC	0
glypican	glypican	NN	B-NP
(	(	-LRB-	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
hspg	hspg	NN	I-NP
)	)	-RRB-	0
[	[	-LRB-	0
48	48	CD	0
49	49	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
parallels	parallels	VBZ	0
our	our	PRP$	0
findings	findings	NNS	0
in	in	IN	0
this	this	DT	0
present	present	JJ	0
report	report	NN	0
,	,	,	0
that	that	WDT	0
cells	cells	NNS	0
interact	interact	VBN	0
with	with	IN	0
III1-C	III1-C	CD	B-NP
through	through	IN	0
integrin	integrin	NN	B-NP
and	and	CC	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
hspg	hspg	NN	I-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
III1-C	III1-C	NNP	B-NP
and	and	CC	0
endostatin	endostatin	NN	B-NP
may	may	MD	0
inhibit	inhibit	VB	0
angiogenesis	angiogenesis	VBN	0
through	through	IN	0
related	related	JJ	0
mechanisms	mechanisms	NNS	0
involving	involving	VBG	0
both	both	DT	0
integrin	integrin	NN	B-NP
and	and	CC	0
HSPGs	HSPGs	JJ	0
.	.	.	0
Future	Future	JJ	0
work	work	NN	0
will	will	MD	0
determine	determine	VB	0
the	the	DT	0
relative	relative	JJ	B-NP
contribution	contribution	NN	I-NP
of	of	IN	0
these	these	DT	0
two	two	CD	0
classes	classes	NNS	0
of	of	IN	0
receptor	receptor	NN	B-NP
in	in	IN	0
the	the	DT	0
iii1-c	iii1-c	NN	B-NP
biological	biological	JJ	I-NP
effect	effect	NN	I-NP
.	.	.	0
Conclusions	Conclusions	NNS	0
We	We	PRP	0
have	have	VBP	0
found	found	VBN	0
that	that	IN	0
cells	cells	NNS	0
can	can	MD	0
interact	interact	VB	0
with	with	IN	0
the	the	DT	0
fibronectin	fibronectin	JJ	0
first	first	JJ	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
,	,	,	0
leading	leading	VBG	0
to	to	TO	0
cell	cell	NN	B-NP
adhesion	adhesion	NN	I-NP
and	and	CC	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
activation	activation	NN	I-NP
,	,	,	0
and	and	CC	0
that	that	IN	0
this	this	DT	0
signaling	signaling	NN	0
requires	requires	VBZ	0
both	both	DT	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
hspg	hspg	NN	I-NP
and	and	CC	0
integrin	integrin	NN	B-NP
.	.	.	0
Results	Results	NNS	0
from	from	IN	0
various	various	JJ	0
independent	independent	JJ	0
types	types	NNS	0
of	of	IN	0
experiments	experiments	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
the	the	DT	0
first	first	JJ	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
of	of	IN	0
fibronectin	fibronectin	NN	B-NP
can	can	MD	0
serve	serve	VB	0
as	as	IN	0
a	a	DT	0
cell	cell	NN	0
binding	binding	JJ	0
domain	domain	NN	0
and	and	CC	0
that	that	IN	0
both	both	DT	0
integrin	integrin	NN	B-NP
and	and	CC	0
cell	cell	NN	0
surface	surface	NN	0
HSPGs	HSPGs	JJ	B-NP
function	function	NN	I-NP
as	as	IN	0
receptor	receptor	NN	B-NP
for	for	IN	0
this	this	DT	0
type	type	NN	0
III	III	NNP	0
repeat	repeat	NN	0
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
Methods	Methods	NNP	0
Materials	Materials	NNPS	0
DMEM	DMEM	NNP	B-NP
and	and	CC	0
glutamine	glutamine	JJ	B-NP
Pen-Strep	Pen-Strep	NN	I-NP
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
Life	Life	NNP	0
Technologies	Technologies	NNPS	0
,	,	,	0
Inc	Inc	NNP	0
.	.	.	0
fetal	fetal	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
bovine	bovine	JJ	I-NP
serum	serum	NN	I-NP
was	was	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
HyClone	HyClone	NNP	0
Laboratories	Laboratories	NNPS	0
,	,	,	0
Inc	Inc	NNP	0
.	.	.	0
Plasma	Plasma	JJ	B-NP
fibronectin	fibronectin	NN	I-NP
was	was	VBD	0
purified	purified	VBN	0
from	from	IN	0
human	human	JJ	0
plasma	plasma	NN	B-NP
by	by	IN	0
gelatin-agarose	gelatin-agarose	JJ	B-NP
affinity	affinity	JJ	I-NP
chromatography	chromatography	NN	I-NP
[	[	-LRB-	0
50	50	CD	0
]	]	-RRB-	0
.	.	.	0
4-20	4-20	CD	0
%	%	NN	0
gradient	gradient	VBZ	B-NP
sds-page	sds-page	NN	I-NP
gel	gel	NN	I-NP
were	were	VBD	0
from	from	IN	0
Novex	Novex	NNP	B-NP
.	.	.	0
Anti-phospho-p44	Anti-phospho-p44	CD	B-NP
/	/	CD	0
42	42	CD	0
MAPK	MAPK	JJ	B-NP
polyclonal	polyclonal	JJ	I-NP
antibody	antibody	NN	I-NP
and	and	CC	0
anti-p44	anti-p44	CD	B-NP
/	/	CD	0
42	42	CD	0
ERK	ERK	JJ	B-NP
polyclonal	polyclonal	JJ	I-NP
antibody	antibody	NN	I-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
new	new	JJ	B-NP
england	england	NNP	I-NP
biolab	biolab	NN	I-NP
.	.	.	0
blocking	blocking	VBG	B-NP
antibody	antibody	NN	I-NP
anti-β1	anti-β1	NN	I-NP
(	(	-LRB-	0
Ha2	Ha2	CD	B-NP
/	/	CD	0
5	5	CD	0
)	)	-RRB-	0
was	was	VBD	0
from	from	IN	0
PharMingen	PharMingen	JJ	0
.	.	.	0
grgdsp	grgdsp	NN	B-NP
peptide	peptide	NN	I-NP
and	and	CC	0
GRADSP	GRADSP	NNP	B-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Life	Life	NNP	0
Technologies	Technologies	NNPS	0
,	,	,	0
Inc	Inc	NNP	0
.	.	.	0
Texas	Texas	NNP	B-NP
red	red	NN	I-NP
and	and	CC	0
FITC	FITC	NNP	B-NP
labeled	labeled	VBD	0
secondary	secondary	JJ	B-NP
antibody	antibody	NN	I-NP
and	and	CC	0
35SO	35SO	CD	0
4	4	CD	0
were	were	VBD	0
from	from	IN	0
ICN	ICN	NNP	B-NP
.	.	.	0
Heparitinase	Heparitinase	NNP	B-NP
,	,	,	0
chondroitinase	chondroitinase	VBG	0
ABC	ABC	NNP	B-NP
and	and	CC	0
mAb	mAb	NNP	B-NP
3G10	3G10	NNP	I-NP
were	were	VBD	0
from	from	IN	0
Seikagaku	Seikagaku	NNP	B-NP
.	.	.	0
anti-fn	anti-fn	NN	B-NP
antibody	antibody	NN	I-NP
were	were	VBD	0
a	a	DT	0
gift	gift	NN	0
of	of	IN	0
Dr.	Dr.	NNP	B-NP
Erkki	Erkki	NNP	B-NP
Ruoslahti	Ruoslahti	NNP	I-NP
(	(	-LRB-	0
Burnham	Burnham	NNP	0
Institute	Institute	NNP	0
)	)	-RRB-	0
.	.	.	0
enhanced	enhanced	VBN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
chemiluminescence	chemiluminescence	NN	I-NP
plus	plus	CC	0
reagent	reagent	NN	B-NP
and	and	CC	0
Hyperfilm	Hyperfilm	NNP	B-NP
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
Amersham	Amersham	NNP	B-NP
.	.	.	0
Complete™	Complete™	NNP	0
protease	protease	VBD	0
inhibitor	inhibitor	JJ	B-NP
cocktail	cocktail	NN	I-NP
tablet	tablet	NN	I-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
boehringer	boehringer	NNP	B-NP
mannheim	mannheim	NNP	I-NP
biochemical	biochemical	JJ	I-NP
.	.	.	0
The	The	DT	0
expression	expression	NN	B-NP
vector	vector	NN	I-NP
pQE-12	pQE-12	NN	I-NP
was	was	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
Qiagen	Qiagen	NNP	B-NP
.	.	.	0
Heparin	Heparin	NNP	B-NP
and	and	CC	0
all	all	DT	0
other	other	JJ	0
chemicals	chemicals	NNS	0
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
Sigma	Sigma	NNP	B-NP
.	.	.	0
The	The	DT	0
purified	purified	JJ	0
glycosaminoglycan	glycosaminoglycan	NN	B-NP
used	used	VBN	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
were	were	VBD	0
a	a	DT	0
generous	generous	JJ	0
gift	gift	NN	0
of	of	IN	0
Dr.	Dr.	NNP	B-NP
Nancy	Nancy	NNP	0
Schwartz	Schwartz	NNP	0
(	(	-LRB-	0
Univ.	Univ.	NNP	B-NP
of	of	IN	0
Chicago	Chicago	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
glycosaminoglycan	glycosaminoglycan	NN	B-NP
were	were	VBD	0
produced	produced	VBN	0
under	under	IN	0
a	a	DT	0
contract	contract	NN	0
from	from	IN	0
the	the	DT	0
National	National	NNP	0
Institute	Institute	NNP	0
of	of	IN	0
Arthritis	Arthritis	NNP	0
and	and	CC	0
Musculoskeletal	Musculoskeletal	NNP	B-NP
and	and	CC	0
Skin	Skin	NNP	0
Diseases	Diseases	NNP	0
(	(	-LRB-	0
NIH	NIH	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
serve	serve	VB	0
as	as	IN	0
reference	reference	NN	B-NP
standard	standard	JJ	I-NP
.	.	.	0
The	The	DT	0
tissue	tissue	NN	0
sources	sources	NNS	0
of	of	IN	0
the	the	DT	0
glycosaminoglycan	glycosaminoglycan	NN	B-NP
were	were	VBD	0
as	as	RB	0
follows	follows	VBZ	0
:	:	:	0
hyaluronic	hyaluronic	JJ	B-NP
acid	acid	NN	I-NP
,	,	,	0
human	human	JJ	0
umbilical	umbilical	JJ	B-NP
cord	cord	NN	I-NP
;	;	:	0
heparan	heparan	JJ	B-NP
sulfate	sulfate	NN	I-NP
,	,	,	0
beef	beef	NN	0
lung	lung	NN	0
;	;	:	0
dermatan	dermatan	JJ	B-NP
sulfate	sulfate	NN	I-NP
,	,	,	0
hog	hog	NN	B-NP
mucosum	mucosum	NN	I-NP
;	;	:	0
chondroitin-4-sulfate	chondroitin-4-sulfate	CD	B-NP
,	,	,	0
notochord	notochord	VBG	0
from	from	IN	0
river	river	NN	0
sturgeon	sturgeon	NNS	0
(	(	-LRB-	0
S.	S.	NNP	0
platorhynchus	platorhynchus	CD	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
chondroitin-6-sulfate	chondroitin-6-sulfate	NNP	B-NP
,	,	,	0
cranial	cranial	JJ	B-NP
cartilage	cartilage	NN	I-NP
of	of	IN	0
river	river	NN	0
sturgeon	sturgeon	NN	0
.	.	.	0
Cell	Cell	NN	0
culture	culture	NN	0
Primary	Primary	JJ	B-NP
rat	rat	NN	I-NP
aortic	aortic	VBZ	0
smooth	smooth	JJ	0
muscle	muscle	NN	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
RASMCs	RASMCs	NNP	B-NP
)	)	-RRB-	0
were	were	VBD	0
isolated	isolated	VBN	0
from	from	IN	0
12-16	12-16	CD	0
week	week	NN	B-NP
old	old	JJ	0
sprague-dawley	sprague-dawley	NN	B-NP
rat	rat	NN	I-NP
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
51	51	CD	0
]	]	-RRB-	0
.	.	.	0
rat	rat	NN	B-NP
aortic	aortic	NN	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
cultured	cultured	VBN	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
supplemented	supplemented	NN	I-NP
with	with	IN	0
10	10	CD	0
%	%	NN	0
fetal	fetal	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
bovine	bovine	JJ	I-NP
serum	serum	NN	I-NP
and	and	CC	0
glutamine	glutamine	JJ	B-NP
Pen-Strep	Pen-Strep	NN	I-NP
.	.	.	0
RASMCs	RASMCs	NNP	0
were	were	VBD	0
typically	typically	RB	0
between	between	IN	0
passages	passages	CD	0
2	2	CD	0
and	and	CC	0
7	7	CD	0
for	for	IN	0
experiments	experiments	NNS	0
.	.	.	0
iii1-c	iii1-c	NN	B-NP
recombinant	recombinant	JJ	I-NP
protein	protein	NN	I-NP
production	production	NN	I-NP
protein	protein	NN	I-NP
and	and	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
(	(	-LRB-	0
previously	previously	RB	0
called	called	VBN	0
III	III	NNP	0
11	11	CD	0
)	)	-RRB-	0
were	were	VBD	0
produced	produced	VBN	0
in	in	IN	0
bacteria	bacteria	NNS	0
and	and	CC	0
purified	purified	VBP	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
2	2	LS	0
]	]	-RRB-	0
.	.	.	0
III1-C	III1-C	NN	B-NP
encompasses	encompasses	FW	0
fibronectin	fibronectin	NN	B-NP
amino	amino	FW	0
acids	acids	FW	0
600-674	600-674	FW	0
(	(	-LRB-	0
Asn-Ala-Pro-Gln-...Thr-Ser-Thr-Pro	Asn-Ala-Pro-Gln-...Thr-Ser-Thr-Pro	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
III	III	NNP	0
11-C	11-C	FW	0
amino	amino	FW	0
acids	acids	FW	0
1,532-1,599	1,532-1,599	FW	0
(	(	-LRB-	0
Leu-Pro-Ser-Ser-...Thr-Ala-Val-Thr	Leu-Pro-Ser-Ser-...Thr-Ala-Val-Thr	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
previously	previously	RB	0
published	published	VBN	0
numbering	numbering	JJ	0
method	method	NN	0
[	[	-LRB-	0
52	52	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
recombinant	recombinant	JJ	0
proteins	proteins	NNS	0
were	were	VBD	0
expressed	expressed	VBN	0
by	by	IN	0
the	the	DT	0
pQE-12	pQE-12	JJ	B-NP
vector	vector	NN	I-NP
,	,	,	0
which	which	WDT	0
places	places	VBZ	0
a	a	DT	0
6-His	6-His	JJ	0
coding	coding	JJ	0
sequence	sequence	NN	0
at	at	IN	0
the	the	DT	0
C-terminus	C-terminus	JJ	B-NP
of	of	IN	0
each	each	DT	0
protein	protein	NN	B-NP
.	.	.	0
The	The	DT	0
proteins	proteins	NNS	0
were	were	VBD	0
purified	purified	VBN	0
on	on	IN	0
ni-agarose	ni-agarose	NN	B-NP
column	column	NN	I-NP
and	and	CC	0
were	were	VBD	0
>	>	CD	0
98	98	CD	0
%	%	NN	0
pure	pure	VBZ	0
as	as	RB	0
judged	judged	VBN	0
by	by	IN	0
SDS-PAGE	SDS-PAGE	JJ	B-NP
and	and	CC	0
coomassie	coomassie	JJ	B-NP
staining	staining	NN	I-NP
.	.	.	0
stock	stock	NN	B-NP
protein	protein	NN	I-NP
solution	solution	NN	I-NP
were	were	VBD	0
typically	typically	RB	0
700	700	CD	0
iii1-c	iii1-c	NN	B-NP
μm	μm	NN	I-NP
and	and	CC	0
520	520	CD	0
μM	μM	NN	B-NP
for	for	IN	0
III	III	NNP	0
11-C	11-C	NNP	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
.	.	.	0
anti-iii1-c	anti-iii1-c	NN	B-NP
antibody	antibody	NN	I-NP
were	were	VBD	0
produced	produced	VBN	0
by	by	IN	0
immunizing	immunizing	JJ	0
rabbits	rabbits	NN	0
with	with	IN	0
III1-C	III1-C	CD	B-NP
.	.	.	0
After	After	IN	0
one	one	CD	0
month	month	NN	0
the	the	DT	0
rabbits	rabbits	NN	0
were	were	VBD	0
boosted	boosted	VBN	0
and	and	CC	0
serum	serum	JJ	0
samples	samples	NNS	0
were	were	VBD	0
collected	collected	VBN	0
every	every	DT	0
two	two	CD	0
weeks	weeks	NNS	0
.	.	.	0
The	The	DT	0
rabbit	rabbit	JJ	B-NP
serum	serum	NN	I-NP
was	was	VBD	0
applied	applied	VBN	0
to	to	TO	0
an	an	DT	0
affinity	affinity	JJ	B-NP
column	column	NN	I-NP
to	to	TO	0
purify	purify	VB	0
the	the	DT	0
anti-iii	anti-iii	NN	B-NP
1-c	1-c	NN	I-NP
antibody	antibody	NN	I-NP
.	.	.	0
In	In	IN	0
order	order	NN	0
to	to	TO	0
avoid	avoid	VB	0
purifying	purifying	JJ	0
antibody	antibody	NN	B-NP
to	to	TO	0
the	the	DT	0
6-His	6-His	JJ	0
tag	tag	NN	0
in	in	IN	0
III1-C	III1-C	NNP	B-NP
,	,	,	0
the	the	DT	0
affinity	affinity	JJ	B-NP
column	column	NN	I-NP
was	was	VBD	0
made	made	VBN	0
with	with	IN	0
a	a	DT	0
GST	GST	NNP	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
.	.	.	0
The	The	DT	0
1	1	CD	0
sttype	sttype	JJ	0
III	III	NNP	0
repeat	repeat	NN	0
of	of	IN	0
fibronectin	fibronectin	NN	B-NP
was	was	VBD	0
expressed	expressed	VBN	0
as	as	IN	0
a	a	DT	0
fusion	fusion	NN	B-NP
protein	protein	NN	I-NP
coupled	coupled	VBN	0
to	to	TO	0
gstorc4	gstorc4	NN	B-NP
,	,	,	0
and	and	CC	0
this	this	DT	0
GST-3FN1	GST-3FN1	JJ	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
was	was	VBD	0
coupled	coupled	VBN	0
to	to	TO	0
Sepharose	Sepharose	NNP	B-NP
and	and	CC	0
used	used	VBN	0
in	in	IN	0
affinity	affinity	JJ	B-NP
purification	purification	NN	I-NP
.	.	.	0
bound	bound	JJ	B-NP
antibody	antibody	NN	I-NP
were	were	VBD	0
eluted	eluted	VBN	0
with	with	IN	0
100	100	CD	0
mM	mM	JJ	B-NP
triethylamine	triethylamine	NN	I-NP
,	,	,	0
pH	pH	JJ	0
11.5	11.5	CD	0
and	and	CC	0
the	the	DT	0
pH	pH	NN	B-NP
was	was	VBD	0
neutralized	neutralized	VBN	0
with	with	IN	0
1	1	CD	0
M	M	NNP	0
tri	tri	NNP	B-NP
,	,	,	0
pH	pH	JJ	0
8	8	CD	0
;	;	:	0
(	(	-LRB-	0
the	the	DT	0
antibody	antibody	NN	B-NP
concentration	concentration	NN	I-NP
was	was	VBD	0
0.4	0.4	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
)	)	-RRB-	0
.	.	.	0
BSA	BSA	NNP	B-NP
(	(	-LRB-	0
0.5	0.5	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
)	)	-RRB-	0
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
stabilize	stabilize	VB	0
the	the	DT	0
antibody	antibody	NN	B-NP
for	for	IN	0
subsequent	subsequent	JJ	0
handling	handling	NN	0
.	.	.	0
The	The	DT	0
antibody	antibody	NN	0
prep	prep	NNS	0
was	was	VBD	0
dialyzed	dialyzed	JJ	0
extensively	extensively	NN	0
against	against	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
before	before	IN	0
use	use	NN	0
.	.	.	0
Cell	Cell	NN	0
attachment	attachment	NN	0
and	and	CC	0
spreading	spreading	VBG	B-NP
assay	assay	NN	I-NP
For	For	IN	0
the	the	DT	0
cell	cell	NN	0
spreading	spreading	VBG	B-NP
assay	assay	NN	I-NP
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
1	1	CD	0
,	,	,	0
fibronectin	fibronectin	NN	B-NP
(	(	-LRB-	0
20	20	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
)	)	-RRB-	0
was	was	VBD	0
coated	coated	VBN	0
onto	onto	IN	0
24-well	24-well	CD	0
dishes	dishes	NNS	0
for	for	IN	0
1	1	CD	0
hr	hr	NN	B-NP
at	at	IN	0
reverse	reverse	JJ	B-NP
transcriptase	transcriptase	NN	I-NP
.	.	.	0
The	The	DT	0
wells	wells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
3	3	CD	0
times	times	NNS	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
before	before	IN	0
adding	adding	VBG	B-NP
cell	cell	NN	I-NP
.	.	.	0
growing	growing	VBG	B-NP
rasmc	rasmc	NN	I-NP
were	were	VBD	0
harvested	harvested	VBN	0
by	by	IN	0
trypsinization	trypsinization	NN	B-NP
and	and	CC	0
collected	collected	VBN	0
into	into	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
BSA	BSA	NN	B-NP
+	+	FW	0
soybean	soybean	NN	B-NP
trypsin	trypsin	NN	I-NP
inhibitor	inhibitor	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
3	3	CD	0
times	times	NNS	0
with	with	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
BSA	BSA	NNP	B-NP
,	,	,	0
then	then	RB	0
resuspended	resuspended	VBN	0
at	at	IN	0
1	1	CD	0
×	×	CD	0
10	10	CD	0
5cells	5cells	CD	0
/	/	CD	0
ml	ml	NN	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
BSA	BSA	NNP	B-NP
,	,	,	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
or	or	CC	0
presence	presence	NN	0
of	of	IN	0
25	25	CD	0
μM	μM	JJ	B-NP
III1-C	III1-C	NN	I-NP
or	or	CC	0
25	25	CD	0
μM	μM	JJ	0
III	III	NNP	0
11-C	11-C	NNP	0
in	in	IN	0
the	the	DT	0
medium	medium	NN	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
seeded	seeded	VBN	0
onto	onto	IN	0
the	the	DT	0
wells	wells	NNS	0
(	(	-LRB-	0
0.5	0.5	CD	0
ml	ml	NN	B-NP
/	/	VBP	I-NP
well	well	RB	I-NP
,	,	,	0
~30	~30	CD	0
%	%	NN	0
confluence	confluence	NN	B-NP
)	)	-RRB-	0
,	,	,	0
placed	placed	VBN	0
in	in	IN	0
a	a	DT	0
37°C	37°C	CD	0
incubator	incubator	NN	B-NP
and	and	CC	0
allowed	allowed	VBN	0
to	to	TO	0
adhere	adhere	VB	0
for	for	IN	0
either	either	DT	0
7	7	CD	0
,	,	,	0
15	15	CD	0
,	,	,	0
30	30	CD	0
,	,	,	0
60	60	CD	0
,	,	,	0
120	120	CD	0
or	or	CC	0
240	240	CD	0
min	min	NN	B-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
then	then	RB	0
fixed	fixed	VBN	B-NP
with	with	IN	0
3.7	3.7	CD	0
%	%	NN	0
paraformaldehyde	paraformaldehyde	NN	B-NP
,	,	,	0
60	60	CD	0
mM	mM	JJ	B-NP
sucrose	sucrose	NN	I-NP
in	in	IN	0
tb	tb	NN	B-NP
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
staining	staining	NN	0
with	with	IN	0
Coomassie	Coomassie	NNP	B-NP
Blue	Blue	NNP	I-NP
dye	dye	NN	I-NP
(	(	-LRB-	0
1	1	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
Coomassie	Coomassie	NNP	I-NP
Brilliant	Brilliant	NNP	I-NP
Blue	Blue	NNP	I-NP
,	,	,	0
45	45	CD	0
%	%	NN	0
MeOH	MeOH	NN	B-NP
,	,	,	0
10	10	CD	0
%	%	NN	0
acetic	acetic	NN	B-NP
acid	acid	NN	I-NP
)	)	-RRB-	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
destained	destained	VBN	0
with	with	IN	0
water	water	NN	0
,	,	,	0
air-dried	air-dried	NNP	0
,	,	,	0
then	then	RB	0
photographed	photographed	VBN	0
with	with	IN	0
a	a	DT	0
Leica	Leica	NNP	B-NP
DM	DM	NNP	I-NP
IRB	IRB	NNP	I-NP
phase	phase	NN	I-NP
microscope	microscope	VBZ	I-NP
connected	connected	VBN	0
to	to	TO	0
a	a	DT	0
Polaroid	Polaroid	NNP	B-NP
CCD	CCD	NNP	I-NP
camera	camera	NN	0
and	and	CC	0
an	an	DT	0
Apple	Apple	NNP	0
Macintosh	Macintosh	NNP	0
computer	computer	NN	0
for	for	IN	0
capturing	capturing	VBG	B-NP
image	image	NN	I-NP
.	.	.	0
To	To	TO	0
quantitate	quantitate	VB	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
spreading	spreading	VBG	0
,	,	,	0
each	each	DT	0
image	image	NN	0
was	was	VBD	0
analyzed	analyzed	VBN	0
with	with	IN	0
the	the	DT	0
NIH	NIH	NNP	B-NP
Image	Image	NNP	0
1.61	1.61	CD	0
application	application	NN	0
to	to	TO	0
determine	determine	VB	0
the	the	DT	0
total	total	JJ	B-NP
amount	amount	NN	I-NP
of	of	IN	0
area	area	NN	0
covered	covered	VBN	0
by	by	IN	0
cells	cells	NNS	0
and	and	CC	0
this	this	DT	0
number	number	NN	0
was	was	VBD	0
divided	divided	VBN	0
by	by	IN	0
the	the	DT	0
total	total	JJ	0
number	number	NN	0
of	of	IN	0
cells	cells	NNS	0
in	in	IN	0
the	the	DT	0
image	image	NN	0
to	to	TO	0
give	give	VB	0
an	an	DT	0
average	average	JJ	0
area	area	NN	0
per	per	IN	0
cell	cell	NN	0
(	(	-LRB-	0
in	in	IN	0
pixel	pixel	NN	B-NP
2	2	CD	0
/	/	CD	0
cell	cell	NN	0
)	)	-RRB-	0
.	.	.	0
Cell	Cell	NN	0
attachment	attachment	NNS	0
assays	assays	VBP	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
2and	2and	CD	0
3were	3were	CD	0
done	done	VBN	0
essentially	essentially	RB	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
2	2	LS	0
]	]	-RRB-	0
.	.	.	0
Briefly	Briefly	RB	0
,	,	,	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
III1-C	III1-C	NNP	B-NP
or	or	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
at	at	IN	0
various	various	JJ	0
concentration	concentration	NN	B-NP
were	were	VBD	0
coated	coated	VBN	0
onto	onto	IN	0
96-well	96-well	CD	0
dishes	dishes	NNS	0
for	for	IN	0
1	1	CD	0
hr	hr	NN	B-NP
at	at	IN	0
reverse	reverse	JJ	B-NP
transcriptase	transcriptase	NN	I-NP
.	.	.	0
The	The	DT	0
wells	wells	NNS	0
were	were	VBD	0
then	then	RB	0
washed	washed	VBD	0
3	3	CD	0
times	times	NNS	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
before	before	IN	0
adding	adding	VBG	B-NP
cell	cell	NN	I-NP
.	.	.	0
growing	growing	VBG	B-NP
rasmc	rasmc	NN	I-NP
were	were	VBD	0
harvested	harvested	VBN	0
by	by	IN	0
trypsinization	trypsinization	NN	B-NP
and	and	CC	0
collected	collected	VBN	0
into	into	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
BSA	BSA	NN	B-NP
+	+	FW	0
soybean	soybean	NN	B-NP
trypsin	trypsin	NN	I-NP
inhibitor	inhibitor	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
3	3	CD	0
times	times	NNS	0
with	with	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
BSA	BSA	NNP	B-NP
,	,	,	0
then	then	RB	0
resuspended	resuspended	VBN	0
at	at	IN	0
4	4	CD	0
×	×	CD	0
10	10	CD	0
5cells	5cells	CD	0
/	/	CD	0
ml	ml	NN	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
BSA	BSA	NN	B-NP
with	with	IN	0
or	or	CC	0
without	without	IN	0
inhibitors	inhibitors	NN	0
,	,	,	0
as	as	RB	0
indicated	indicated	VBN	0
in	in	IN	0
the	the	DT	0
figures	figures	NNS	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
seeded	seeded	VBN	0
onto	onto	IN	0
the	the	DT	0
coated	coated	JJ	0
wells	wells	NNS	0
and	and	CC	0
allowed	allowed	VBN	0
to	to	TO	0
adhere	adhere	VB	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
at	at	IN	0
37°C	37°C	CD	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
then	then	RB	0
fixed	fixed	VBN	B-NP
with	with	IN	0
3.7	3.7	CD	0
%	%	NN	0
paraformaldehyde	paraformaldehyde	NN	B-NP
,	,	,	0
60	60	CD	0
mM	mM	JJ	B-NP
sucrose	sucrose	NN	I-NP
in	in	IN	0
tb	tb	NN	B-NP
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
20	20	CD	0
%	%	NN	0
methanol	methanol	NN	0
,	,	,	0
and	and	CC	0
staining	staining	NN	0
in	in	IN	0
0.5	0.5	CD	0
%	%	NN	0
crystal	crystal	NN	0
violet	violet	NN	0
in	in	IN	0
20	20	CD	0
%	%	NN	0
methanol	methanol	NN	0
.	.	.	0
Stained	Stained	JJ	0
cells	cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
with	with	IN	0
water	water	NN	0
and	and	CC	0
the	the	DT	0
dye	dye	NN	0
was	was	VBD	0
solubilized	solubilized	VBN	0
with	with	IN	0
0.1	0.1	CD	0
M	M	NNP	0
sodium	sodium	NN	B-NP
citrate	citrate	NN	I-NP
,	,	,	0
pH	pH	JJ	0
4.2	4.2	CD	0
,	,	,	0
50	50	CD	0
%	%	NN	0
ethanol	ethanol	NN	B-NP
.	.	.	0
Attachment	Attachment	NNP	0
was	was	VBD	0
quantitated	quantitated	VBN	0
by	by	IN	0
measuring	measuring	VBG	0
the	the	DT	0
absorbance	absorbance	NN	B-NP
at	at	IN	0
600	600	CD	0
nm.	nm.	CD	B-NP
125I	125I	CD	0
cell	cell	NN	0
surface	surface	NN	0
labeling	labeling	NNS	0
and	and	CC	0
affinity	affinity	NN	B-NP
chromatography	chromatography	VBP	0
The	The	DT	0
procedure	procedure	NN	0
was	was	VBD	0
a	a	DT	0
modification	modification	NN	B-NP
of	of	IN	0
the	the	DT	0
procedure	procedure	NN	0
used	used	VBN	0
to	to	TO	0
isolate	isolate	VB	0
the	the	DT	0
fibronectin	fibronectin	JJ	B-NP
receptor	receptor	NN	I-NP
and	and	CC	0
other	other	JJ	0
integrin	integrin	NN	B-NP
[	[	-LRB-	0
27	27	CD	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
affinity	affinity	JJ	B-NP
resin	resin	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
coupling	coupling	JJ	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
III1-C	III1-C	NNP	B-NP
or	or	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
to	to	TO	0
CNBr-activated	CNBr-activated	NNP	B-NP
Sepharose	Sepharose	NNP	I-NP
CL-4B	CL-4B	NNP	I-NP
according	according	VBG	0
to	to	TO	0
the	the	DT	0
manufacturer	manufacturer	NN	0
's	's	POS	0
recommendation	recommendation	NN	B-NP
.	.	.	0
The	The	DT	0
protein	protein	NN	B-NP
concentration	concentration	NN	I-NP
was	was	VBD	0
typically	typically	RB	0
4-5	4-5	CD	0
mg	mg	CD	0
fibronectin	fibronectin	CD	0
/	/	CD	0
ml	ml	NN	0
of	of	IN	0
resin	resin	NN	B-NP
,	,	,	0
or	or	CC	0
8-10	8-10	CD	0
iii1-c	iii1-c	NN	B-NP
resin	resin	NN	I-NP
mg	mg	CD	I-NP
protein/ml	protein/ml	NN	I-NP
and	and	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
.	.	.	0
Ten	Ten	CD	0
15-cm	15-cm	CD	0
dishes	dishes	NNS	0
of	of	IN	0
rat	rat	NN	B-NP
aortic	aortic	NN	I-NP
smooth	smooth	JJ	I-NP
muscle	muscle	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
washed	washed	VBN	0
twice	twice	RB	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
then	then	RB	0
harvested	harvested	VBN	0
by	by	IN	0
detachment	detachment	NN	0
of	of	IN	0
cells	cells	NNS	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
+	+	CD	0
10	10	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
twice	twice	RB	0
more	more	JJR	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
then	then	RB	0
resuspended	resuspended	VBN	0
at	at	IN	0
4	4	CD	0
×	×	CD	0
10	10	CD	0
7cells	7cells	CD	0
/	/	CD	0
ml	ml	NN	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
labeled	labeled	VBN	0
with	with	IN	0
1	1	CD	0
mCi	mCi	JJ	0
Na	Na	NNP	0
125I	125I	NNP	0
and	and	CC	0
lactoperoxidase-H	lactoperoxidase-H	JJ	B-NP
2	2	CD	0
O	O	CD	0
2	2	CD	0
,	,	,	0
as	as	RB	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
27	27	CD	0
]	]	-RRB-	0
.	.	.	0
After	After	IN	0
labeling	labeling	VBG	0
the	the	DT	0
cell	cell	NN	0
pellet	pellet	NNS	0
was	was	VBD	0
washed	washed	VBN	0
with	with	IN	0
ice-cold	ice-cold	NNP	0
PBS	PBS	NNP	0
+	+	NNP	0
NaN	NaN	NNP	0
3	3	CD	0
,	,	,	0
then	then	RB	0
lysed	lysed	VBN	0
in	in	IN	0
2	2	CD	0
volumes	volumes	NNS	0
of	of	IN	0
OG	OG	NNP	0
Lysis	Lysis	NNP	0
Buffer	Buffer	NNP	0
(	(	-LRB-	0
200	200	CD	0
mM	mM	JJ	0
octylglucoside	octylglucoside	NN	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	0
CaCl	CaCl	JJ	0
2	2	CD	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	0
2	2	CD	0
,	,	,	0
TBS	TBS	NNP	0
,	,	,	0
PMSF	PMSF	NNP	0
)	)	-RRB-	0
at	at	IN	0
4°C	4°C	CD	0
.	.	.	0
The	The	DT	0
lysate	lysate	NN	0
was	was	VBD	0
spun	spun	VBN	0
at	at	IN	0
14,000	14,000	CD	0
×	×	CD	0
g	g	NN	0
for	for	IN	0
15	15	CD	0
min	min	NN	0
at	at	IN	0
4°C	4°C	NNP	0
,	,	,	0
and	and	CC	0
the	the	DT	0
supernatant	supernatant	NN	0
was	was	VBD	0
used	used	VBN	0
for	for	IN	0
affinity	affinity	JJ	0
chromatography	chromatography	NN	0
.	.	.	0
Lysate	Lysate	NNP	0
was	was	VBD	0
applied	applied	VBN	0
to	to	TO	0
the	the	DT	0
affinity	affinity	JJ	0
columns	columns	NNS	0
(	(	-LRB-	0
0.2	0.2	CD	0
ml	ml	CD	0
lysate	lysate	NNS	0
was	was	VBD	0
applied	applied	VBN	0
to	to	TO	0
0.1	0.1	CD	0
ml	ml	NNS	0
affinity	affinity	VBP	0
matrix	matrix	JJ	0
bed	bed	NN	0
volume	volume	NN	0
)	)	-RRB-	0
,	,	,	0
flow	flow	NN	0
through	through	IN	0
fractions	fractions	NNS	0
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
passed	passed	VBN	0
over	over	IN	0
the	the	DT	0
columns	columns	NNS	0
twice	twice	RB	0
more	more	RBR	0
.	.	.	0
Columns	Columns	NNS	0
were	were	VBD	0
washed	washed	VBN	0
with	with	IN	0
10	10	CD	0
column	column	NN	0
volumes	volumes	NNS	0
of	of	IN	0
Wash	Wash	NNP	B-NP
Buffer	Buffer	NNP	I-NP
(	(	-LRB-	0
40	40	CD	0
mM	mM	JJ	B-NP
octylglucoside	octylglucoside	NN	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	0
CaCl	CaCl	JJ	B-NP
2	2	CD	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	B-NP
2	2	CD	0
,	,	,	0
tb	tb	NN	B-NP
)	)	-RRB-	0
,	,	,	0
before	before	IN	0
elution	elution	NN	B-NP
of	of	IN	0
bound	bound	JJ	0
protein	protein	NN	B-NP
with	with	IN	0
10	10	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NN	I-NP
in	in	IN	0
Wash	Wash	NNP	B-NP
Buffer	Buffer	NNP	I-NP
.	.	.	0
Samples	Samples	NNS	0
from	from	IN	0
the	the	DT	0
final	final	JJ	B-NP
wash	wash	NN	I-NP
and	and	CC	0
eluted	eluted	JJ	B-NP
sample	sample	NN	I-NP
were	were	VBD	0
separated	separated	VBN	0
on	on	IN	0
4-20	4-20	CD	0
%	%	NN	0
gradient	gradient	NN	B-NP
novex	novex	NN	I-NP
gel	gel	NN	I-NP
,	,	,	0
the	the	DT	0
gels	gels	NN	0
were	were	VBD	0
dried	dried	VBN	0
and	and	CC	0
exposed	exposed	VBN	0
to	to	TO	0
phosphorimager	phosphorimager	VB	0
cassette	cassette	NN	0
and	and	CC	0
the	the	DT	0
radioactive	radioactive	JJ	B-NP
signal	signal	NN	I-NP
was	was	VBD	0
measured	measured	VBN	0
with	with	IN	0
a	a	DT	0
Storm	Storm	NN	B-NP
phosphorimager	phosphorimager	NN	I-NP
instrument	instrument	NN	I-NP
.	.	.	0
MAPK	MAPK	NNP	B-NP
assay	assay	NN	I-NP
and	and	CC	0
immunoblotting	immunoblotting	JJ	B-NP
well	well	JJ	I-NP
of	of	IN	0
a	a	DT	0
6-well	6-well	JJ	0
plate	plate	NN	0
were	were	VBD	0
coated	coated	VBN	0
with	with	IN	0
either	either	DT	0
20	20	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
fibronectin	fibronectin	NN	I-NP
,	,	,	0
25	25	CD	0
μM	μM	JJ	B-NP
III1-C	III1-C	NN	I-NP
or	or	CC	0
25	25	CD	0
μM	μM	JJ	0
III	III	NNP	0
11-C	11-C	NNP	0
for	for	IN	0
1	1	CD	0
hr	hr	NN	B-NP
at	at	IN	0
reverse	reverse	JJ	B-NP
transcriptase	transcriptase	NN	I-NP
.	.	.	0
Wells	Wells	NNP	0
were	were	VBD	0
washed	washed	VBN	0
3	3	CD	0
times	times	NNS	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
before	before	IN	0
adding	adding	VBG	B-NP
cell	cell	NN	I-NP
.	.	.	0
growing	growing	VBG	B-NP
rasmc	rasmc	NN	I-NP
were	were	VBD	0
harvested	harvested	VBN	0
by	by	IN	0
trypsinization	trypsinization	NN	B-NP
and	and	CC	0
collected	collected	VBN	0
into	into	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
BSA	BSA	NN	B-NP
+	+	FW	0
soybean	soybean	NN	B-NP
trypsin	trypsin	NN	I-NP
inhibitor	inhibitor	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
3	3	CD	0
times	times	NNS	0
with	with	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
BSA	BSA	NNP	B-NP
,	,	,	0
then	then	RB	0
resuspended	resuspended	VBN	0
at	at	IN	0
3	3	CD	0
×	×	CD	0
10	10	CD	0
5cells	5cells	CD	0
/	/	CD	0
ml	ml	NN	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
BSA	BSA	NN	B-NP
with	with	IN	0
or	or	CC	0
without	without	IN	0
blocking	blocking	VBG	B-NP
agent	agent	NN	I-NP
integrin	integrin	NNS	I-NP
or	or	CC	0
other	other	JJ	0
additions	additions	NNS	0
,	,	,	0
as	as	RB	0
described	described	VBN	0
in	in	IN	0
the	the	DT	0
figure	figure	NN	B-NP
legend	legend	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
either	either	RB	0
left	left	VBN	0
in	in	IN	0
suspension	suspension	NN	0
(	(	-LRB-	0
for	for	IN	0
suspended	suspended	VBN	0
and	and	CC	0
pdgf	pdgf	NN	B-NP
stimulated	stimulated	NN	I-NP
sample	sample	NN	I-NP
)	)	-RRB-	0
or	or	CC	0
were	were	VBD	0
seeded	seeded	VBN	0
onto	onto	IN	0
the	the	DT	0
coated	coated	JJ	0
wells	wells	NNS	0
(	(	-LRB-	0
1	1	CD	0
ml	ml	NN	0
per	per	IN	0
well	well	RB	0
)	)	-RRB-	0
and	and	CC	0
allowed	allowed	VBN	0
to	to	TO	0
adhere	adhere	VB	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
at	at	IN	0
37°C	37°C	NNP	0
,	,	,	0
or	or	CC	0
for	for	IN	0
the	the	DT	0
times	times	NNS	0
indicated	indicated	VBD	0
in	in	IN	0
the	the	DT	0
figure	figure	NN	B-NP
legend	legend	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
stimulated	stimulated	VBN	0
with	with	IN	0
PDGF	PDGF	NNP	B-NP
(	(	-LRB-	0
2	2	LS	0
ng	ng	NNP	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
PDGF-BB	PDGF-BB	NN	I-NP
)	)	-RRB-	0
received	received	VBD	0
the	the	DT	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
10	10	CD	0
min	min	NN	B-NP
before	before	IN	0
collecting	collecting	VBG	0
the	the	DT	0
cells	cells	NNS	0
for	for	IN	0
lysi	lysi	NN	B-NP
,	,	,	0
while	while	IN	0
the	the	DT	0
other	other	JJ	0
samples	samples	NNS	0
received	received	VBD	0
no	no	DT	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
or	or	CC	0
serum	serum	NN	B-NP
.	.	.	0
After	After	IN	0
the	the	DT	0
adhesion	adhesion	JJ	B-NP
period	period	NN	I-NP
plate	plate	NN	I-NP
were	were	VBD	0
placed	placed	VBN	0
on	on	IN	0
ice	ice	NN	0
,	,	,	0
unattached	unattached	JJ	0
cells	cells	NNS	0
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
spun	spun	VBD	0
down	down	RB	0
,	,	,	0
while	while	IN	0
cell	cell	NN	B-NP
monolayer	monolayer	NN	I-NP
were	were	VBD	0
washed	washed	VBN	0
once	once	RB	0
with	with	IN	0
ice	ice	NN	0
cold	cold	JJ	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
then	then	RB	0
lysed	lysed	VBN	0
with	with	IN	0
SDS-PAGE	SDS-PAGE	JJ	B-NP
sample	sample	NN	I-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
100	100	CD	0
μl	μl	NN	B-NP
/	/	VBP	I-NP
well	well	RB	I-NP
)	)	-RRB-	0
.	.	.	0
centrifuged	centrifuged	NN	B-NP
pellet	pellet	NN	I-NP
of	of	IN	0
unattached	unattached	JJ	0
cells	cells	NNS	0
were	were	VBD	0
combined	combined	VBN	0
with	with	IN	0
the	the	DT	0
appropriate	appropriate	JJ	0
monolayer	monolayer	JJ	B-NP
lysate	lysate	JJ	I-NP
sample	sample	NN	I-NP
and	and	CC	0
the	the	DT	0
samples	samples	NNS	0
were	were	VBD	0
heated	heated	VBN	0
to	to	TO	0
100°C	100°C	CD	0
for	for	IN	0
5	5	CD	0
min	min	NN	B-NP
.	.	.	0
Samples	Samples	NNS	0
were	were	VBD	0
separated	separated	VBN	0
on	on	IN	0
4-20	4-20	CD	0
%	%	NN	0
gradient	gradient	NN	B-NP
novex	novex	NN	I-NP
gel	gel	NN	I-NP
,	,	,	0
transferred	transferred	VBN	0
to	to	TO	0
immobilon	immobilon	NN	B-NP
p	p	NN	I-NP
membrane	membrane	NN	I-NP
,	,	,	0
blocked	blocked	VBN	0
with	with	IN	0
5	5	CD	0
%	%	NN	0
nonfat	nonfat	VBZ	0
dry	dry	JJ	0
milk	milk	NN	0
in	in	IN	0
TBS-Tween	TBS-Tween	NNP	B-NP
,	,	,	0
then	then	RB	0
probed	probed	VBN	0
with	with	IN	0
anti-phospho-p44	anti-phospho-p44	CD	B-NP
/	/	CD	0
42	42	CD	0
MAPK	MAPK	JJ	B-NP
antibody	antibody	NN	I-NP
according	according	VBG	0
to	to	TO	0
the	the	DT	0
manufacturer	manufacturer	NN	0
's	's	POS	0
recommendation	recommendation	NN	B-NP
.	.	.	0
Blots	Blots	NNP	0
were	were	VBD	0
then	then	RB	0
stripped	stripped	VBN	0
in	in	IN	0
Stripping	Stripping	NNP	B-NP
Buffer	Buffer	NNP	I-NP
(	(	-LRB-	0
2	2	CD	0
%	%	NN	0
sd	sd	NN	B-NP
,	,	,	0
100	100	CD	0
mM	mM	JJ	B-NP
β-mercaptoethanol	β-mercaptoethanol	NN	I-NP
,	,	,	0
62.5	62.5	CD	0
mm	mm	NN	B-NP
tri	tri	NNP	I-NP
,	,	,	0
pH	pH	JJ	0
6.7	6.7	CD	0
)	)	-RRB-	0
at	at	IN	0
50°C	50°C	CD	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
,	,	,	0
washed	washed	VBD	0
4	4	CD	0
times	times	NNS	0
with	with	IN	0
TBS-Tween	TBS-Tween	NNP	B-NP
,	,	,	0
blocked	blocked	VBN	0
with	with	IN	0
5	5	CD	0
%	%	NN	0
nonfat	nonfat	VBZ	0
dry	dry	JJ	0
milk	milk	NN	0
in	in	IN	0
TBS-Tween	TBS-Tween	NNP	B-NP
,	,	,	0
then	then	RB	0
probed	probed	VBN	0
with	with	IN	0
anti-p44	anti-p44	CD	B-NP
/	/	CD	0
42	42	CD	0
ERK	ERK	JJ	B-NP
antibody	antibody	NN	I-NP
according	according	VBG	0
to	to	TO	0
the	the	DT	0
manufacturer	manufacturer	NN	0
's	's	POS	0
recommendation	recommendation	NN	B-NP
.	.	.	0
All	All	DT	0
blots	blots	NN	0
were	were	VBD	0
developed	developed	VBN	0
with	with	IN	0
the	the	DT	0
enhanced	enhanced	VBN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
chemiluminescence	chemiluminescence	NN	I-NP
plus	plus	CC	0
reagent	reagent	NN	B-NP
and	and	CC	0
exposed	exposed	VBN	0
to	to	TO	0
Hyperfilm	Hyperfilm	NNP	B-NP
.	.	.	0
For	For	IN	0
both	both	DT	0
antibody	antibody	NN	B-NP
the	the	DT	0
typical	typical	JJ	0
exposure	exposure	NN	B-NP
time	time	NN	I-NP
were	were	VBD	0
under	under	IN	0
5	5	CD	0
min	min	NN	B-NP
.	.	.	0
Heparitinase	Heparitinase	JJ	B-NP
treatment	treatment	NN	I-NP
of	of	IN	0
cells	cells	NNS	0
and	and	CC	0
lysate	lysate	NN	B-NP
6	6	CD	0
well	well	RB	0
plates	plates	RB	0
were	were	VBD	0
coated	coated	VBN	0
with	with	IN	0
either	either	DT	0
fibronectin	fibronectin	NN	B-NP
,	,	,	0
III1-C	III1-C	NNP	B-NP
or	or	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
as	as	RB	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
growing	growing	VBG	B-NP
rasmc	rasmc	NN	I-NP
were	were	VBD	0
harvested	harvested	VBN	0
by	by	IN	0
trypsinization	trypsinization	NN	B-NP
and	and	CC	0
washed	washed	VBN	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
+	+	NNP	0
BSA	BSA	NNP	B-NP
as	as	RB	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
For	For	IN	0
GAGase	GAGase	JJ	B-NP
treatment	treatment	NN	I-NP
of	of	IN	0
intact	intact	JJ	0
cells	cells	NNS	0
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
remained	remained	VBD	0
in	in	IN	0
suspension	suspension	NN	0
and	and	CC	0
received	received	VBD	0
either	either	RB	0
no	no	DT	0
enzyme	enzyme	NN	B-NP
or	or	CC	0
0.1	0.1	CD	0
u	u	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
heparitinasa	heparitinasa	NN	I-NP
or	or	CC	0
0.1	0.1	CD	0
u	u	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
chondroitinase	chondroitinase	NN	I-NP
ABC	ABC	NNP	I-NP
for	for	IN	0
1	1	CD	0
hr	hr	NN	B-NP
at	at	IN	0
37°C	37°C	CD	0
with	with	IN	0
constant	constant	JJ	0
gentle	gentle	JJ	0
rotation	rotation	NN	B-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
then	then	RB	0
plated	plated	VBN	0
onto	onto	IN	0
precoated	precoated	JJ	0
dishes	dishes	NNS	0
and	and	CC	0
processed	processed	VBN	0
for	for	IN	0
immunoblotting	immunoblotting	NN	B-NP
with	with	IN	0
anti-phospho-p44	anti-phospho-p44	CD	B-NP
/	/	CD	0
42	42	CD	0
MAPK	MAPK	JJ	B-NP
antibody	antibody	NN	I-NP
as	as	IN	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
after	after	IN	0
heparitinase	heparitinase	JJ	B-NP
digestion	digestion	JJ	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
lysed	lysed	VBN	0
directly	directly	RB	0
in	in	IN	0
sample	sample	NN	B-NP
buffer	buffer	NN	I-NP
sd	sd	NN	I-NP
and	and	CC	0
analyzed	analyzed	VBD	0
by	by	IN	0
immunoblotting	immunoblotting	NN	B-NP
with	with	IN	0
the	the	DT	0
3G10	3G10	NNP	B-NP
mAb	mAb	NNP	I-NP
(	(	-LRB-	0
essentially	essentially	RB	0
as	as	RB	0
described	described	VBN	0
above	above	IN	0
for	for	IN	0
anti-phospho-p44	anti-phospho-p44	CD	B-NP
/	/	CD	0
42	42	CD	0
MAPK	MAPK	CD	B-NP
immunoblotting	immunoblotting	CD	I-NP
)	)	-RRB-	0
.	.	.	0
For	For	IN	0
cell	cell	NN	B-NP
lysate	lysate	NN	I-NP
gagase	gagase	NN	I-NP
treatment	treatment	NN	I-NP
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
lysed	lysed	VBN	0
on	on	IN	0
ice	ice	NN	0
in	in	IN	0
NP40	NP40	NNP	B-NP
Lysis	Lysis	NNP	I-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
1	1	CD	0
%	%	NN	0
Nonidet	Nonidet	NNP	B-NP
P	P	NNP	I-NP
40	40	CD	0
,	,	,	0
150	150	CD	0
mM	mM	JJ	B-NP
NaCl	NaCl	NN	I-NP
,	,	,	0
50	50	CD	0
mm	mm	NN	B-NP
tri	tri	NNP	I-NP
,	,	,	0
pH	pH	NNP	B-NP
8.0	8.0	NNP	0
)	)	-RRB-	0
plus	plus	CC	0
protease	protease	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
(	(	-LRB-	0
Complete™	Complete™	FW	0
protease	protease	NN	B-NP
inhibitor	inhibitor	NN	I-NP
cocktail	cocktail	NN	I-NP
)	)	-RRB-	0
at	at	IN	0
2	2	CD	0
×	×	CD	0
10	10	CD	0
6cells	6cells	CD	0
/	/	CD	0
ml	ml	NNS	0
.	.	.	0
Insoluble	Insoluble	JJ	0
material	material	NN	0
was	was	VBD	0
removed	removed	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
at	at	IN	0
14,000	14,000	CD	0
×	×	CD	0
g	g	NN	0
for	for	IN	0
15	15	CD	0
min	min	NN	B-NP
at	at	IN	0
4°C	4°C	CD	0
.	.	.	0
Lysate	Lysate	NNP	B-NP
was	was	VBD	0
prepared	prepared	VBN	0
for	for	IN	0
heparitinase	heparitinase	JJ	B-NP
treatment	treatment	NN	I-NP
by	by	IN	0
adding	adding	VBG	0
CaCl	CaCl	JJ	B-NP
2	2	CD	0
to	to	TO	0
10	10	CD	0
μM	μM	JJ	B-NP
final	final	JJ	I-NP
concentration	concentration	NN	I-NP
.	.	.	0
Heparitinase	Heparitinase	NNP	B-NP
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
0.1	0.1	CD	0
u	u	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
final	final	JJ	I-NP
concentration	concentration	NN	I-NP
and	and	CC	0
the	the	DT	0
lysate	lysate	NN	B-NP
was	was	VBD	0
incubated	incubated	VBN	0
at	at	IN	0
37°C	37°C	CD	0
for	for	IN	0
1	1	CD	0
hr	hr	NN	B-NP
.	.	.	0
The	The	DT	0
lysate	lysate	NN	B-NP
was	was	VBD	0
then	then	RB	0
applied	applied	VBN	0
to	to	TO	0
chromatography	chromatography	JJ	B-NP
column	column	NN	I-NP
affinity	affinity	VB	I-NP
as	as	RB	0
described	described	VBD	0
below.	below.	CD	0
35SO	35SO	CD	0
4labeling	4labeling	CD	0
and	and	CC	0
affinity	affinity	JJ	B-NP
chromatography	chromatography	NN	I-NP
Growing	Growing	VBG	0
RASMCs	RASMCs	JJ	B-NP
labeled	labeled	NN	I-NP
for	for	IN	0
20	20	CD	0
hr	hr	NN	B-NP
at	at	IN	0
37°C	37°C	CD	0
with	with	IN	0
200	200	CD	0
μCi	μCi	JJ	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
35S04	35S04	CD	I-NP
in	in	IN	0
DMEM	DMEM	NNP	B-NP
+	+	CD	0
10	10	CD	0
%	%	NN	0
dialyzed	dialyzed	VBD	0
FCS	FCS	NNP	B-NP
+	+	NNP	0
Pen-Strep	Pen-Strep	NNP	B-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
placed	placed	VBN	0
on	on	IN	0
ice	ice	NN	0
,	,	,	0
washed	washed	VBD	0
once	once	RB	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
then	then	RB	0
lysed	lysed	VBN	0
in	in	IN	0
NP40	NP40	NNP	B-NP
Lysis	Lysis	NNP	I-NP
buffer	buffer	NN	I-NP
as	as	IN	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
III1-C	III1-C	NNP	B-NP
and	and	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
columns	columns	NNS	0
were	were	VBD	0
produced	produced	VBN	0
as	as	RB	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
cell	cell	NN	B-NP
lysate	lysate	NN	I-NP
were	were	VBD	0
applied	applied	VBN	0
to	to	TO	0
III1-C	III1-C	CD	B-NP
or	or	CC	0
III	III	NNP	0
11-C	11-C	NNP	0
columns	columns	NNS	0
(	(	-LRB-	0
typically	typically	RB	0
500	500	CD	0
μl	μl	CD	B-NP
lysata	lysata	NN	I-NP
was	was	VBD	0
applied	applied	VBN	0
to	to	TO	0
250	250	CD	0
μl	μl	NN	B-NP
affinity	affinity	VBP	I-NP
matrix	matrix	JJ	I-NP
bed	bed	NN	I-NP
volume	volume	NN	I-NP
)	)	-RRB-	0
,	,	,	0
flow	flow	NN	0
through	through	IN	0
fractions	fractions	NNS	0
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
passed	passed	VBN	0
over	over	IN	0
the	the	DT	0
columns	columns	NNS	0
twice	twice	RB	0
more	more	RBR	0
.	.	.	0
The	The	DT	0
final	final	JJ	B-NP
flow	flow	NN	I-NP
through	through	IN	0
fractions	fractions	NNS	0
were	were	VBD	0
then	then	RB	0
collected	collected	VBN	0
.	.	.	0
Columns	Columns	NNS	0
were	were	VBD	0
washed	washed	VBN	0
with	with	IN	0
10	10	CD	0
column	column	NN	0
volumes	volumes	NNS	0
of	of	IN	0
NP40	NP40	NNP	B-NP
Lysis	Lysis	NNP	I-NP
buffer	buffer	NN	I-NP
,	,	,	0
then	then	RB	0
bound	bound	VBN	0
material	material	NN	0
was	was	VBD	0
removed	removed	VBN	0
by	by	IN	0
boiling	boiling	VBG	0
the	the	DT	0
sepharose	sepharose	NN	B-NP
bead	bead	NN	I-NP
in	in	IN	0
2	2	CD	0
column	column	NN	0
volumes	volumes	NNS	0
of	of	IN	0
sample	sample	NN	B-NP
buffer	buffer	NN	I-NP
sd	sd	NN	I-NP
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
the	the	DT	0
bound	bound	JJ	0
material	material	NN	0
was	was	VBD	0
first	first	JJ	0
eluted	eluted	NN	0
with	with	IN	0
2	2	CD	0
column	column	NN	0
volumes	volumes	NNS	0
of	of	IN	0
8	8	CD	0
M	M	NNP	0
urea	urea	NN	B-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
8	8	CD	0
M	M	NNP	0
urea	urea	NN	B-NP
,	,	,	0
0.1	0.1	CD	0
M	M	NNP	0
NaH	NaH	NNP	B-NP
2	2	CD	0
PO	PO	CD	B-NP
4	4	CD	0
,	,	,	0
10	10	CD	0
mm	mm	NN	B-NP
tri	tri	NNP	I-NP
,	,	,	0
pH	pH	NNP	B-NP
8.0	8.0	NNP	0
)	)	-RRB-	0
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
washing	washing	VBG	0
with	with	IN	0
10	10	CD	0
column	column	NN	0
volumes	volumes	NNS	0
of	of	IN	0
NP40	NP40	NNP	B-NP
Lysis	Lysis	NNP	I-NP
buffer	buffer	NN	I-NP
,	,	,	0
and	and	CC	0
then	then	RB	0
removing	removing	VBG	0
any	any	DT	0
remaining	remaining	VBG	0
bound	bound	VBN	0
material	material	NN	0
by	by	IN	0
boiling	boiling	VBG	0
the	the	DT	0
sepharose	sepharose	NN	B-NP
bead	bead	NN	I-NP
in	in	IN	0
sample	sample	NN	B-NP
buffer	buffer	NN	I-NP
sd	sd	NN	I-NP
.	.	.	0
Samples	Samples	NNS	0
were	were	VBD	0
separated	separated	VBN	0
on	on	IN	0
4-20	4-20	CD	0
%	%	NN	0
novex	novex	NN	B-NP
sds-page	sds-page	NN	I-NP
gel	gel	NN	I-NP
,	,	,	0
the	the	DT	0
gels	gels	NN	0
were	were	VBD	0
fixed	fixed	VBN	B-NP
and	and	CC	0
dried	dried	NNS	0
and	and	CC	0
the	the	DT	0
radioactive	radioactive	JJ	B-NP
material	material	NN	I-NP
was	was	VBD	0
detected	detected	VBN	0
by	by	IN	0
using	using	VBG	0
a	a	DT	0
phosphorimager	phosphorimager	NN	B-NP
.	.	.	0
